{ "version": "2.2", "instance": { "acet-20251231.htm": { "nsprefix": "acet", "nsuri": "http://www.adicetbio.com/20251231", "dts": { "inline": { "local": [ "acet-20251231.htm" ] }, "schema": { "local": [ "acet-20251231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd", "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] } }, "keyStandard": 37, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 5, "http://xbrl.sec.gov/dei/2025": 5 }, "contextCount": 3, "entityCount": 1, "segmentCount": 0, "elementCount": 999, "unitCount": 2, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2025": 37 }, "report": { "R1": { "role": "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "75000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_196ddba3-598c-4159-96d7-a18f852afd5f", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "acet-20251231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_196ddba3-598c-4159-96d7-a18f852afd5f", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "acet-20251231.htm", "first": true, "unique": true } } }, "tag": { "acet_ADITwoOneTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ADITwoOneTwoMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "ADI Two One Two [Member]", "documentation": "ADI Two One Two Member", "terseLabel": "ADI-212" } } }, "auth_ref": [] }, "acet_ADITwoSevenZeroExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ADITwoSevenZeroExpenses", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails": { "parentTag": "acet_TotalExternalProgramExpensesForProductCandidates", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "ADI Two Seven Zero Expenses", "documentation": "ADI Two Seven Zero Expenses", "terseLabel": "ADI-270" } } }, "auth_ref": [] }, "acet_ADITwoSevenZeroExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ADITwoSevenZeroExpensesMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "ADI Two Seven Zero Expenses [Member]", "documentation": "ADI Two Seven Zero Expenses [Member]", "terseLabel": "ADI-270" } } }, "auth_ref": [] }, "acet_ADIZeroZeroOneExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ADIZeroZeroOneExpenses", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails": { "parentTag": "acet_TotalExternalProgramExpensesForProductCandidates", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ADI-001", "label": "ADI Zero Zero One Expenses", "documentation": "ADI Zero Zero One Expenses" } } }, "auth_ref": [] }, "acet_ADIZeroZeroOneExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ADIZeroZeroOneExpensesMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ADI-001", "label": "ADI Zero Zero One Expenses [Member]", "documentation": "ADI Zero Zero One Expenses [Member]" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountingStandardsUpdate201602Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountingStandardsUpdate201602Member", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Topic 842", "label": "Accounting Standards Update 2016-02 [Member]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued and Other Current Liabilities", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Payable, Current", "totalLabel": "Accounts Payable, Current, Total", "terseLabel": "Accounts payable" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableGrossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsReceivableGrossCurrent", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable", "label": "Accounts Receivable, before Allowance for Credit Loss, Current" } } }, "auth_ref": [] }, "us-gaap_AccruedBonusesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccruedBonusesCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount equal to pro-rated bonus", "label": "Accrued Bonuses" } } }, "auth_ref": [] }, "acet_AccruedCmoCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AccruedCmoCosts", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesSummaryOfAccruedAndOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesSummaryOfAccruedAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued CDMO costs", "label": "Accrued CMO costs", "documentation": "Accrued CMO costs" } } }, "auth_ref": [] }, "acet_AccruedCroCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AccruedCroCosts", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesSummaryOfAccruedAndOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesSummaryOfAccruedAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Accrued CRO costs", "terseLabel": "Accrued CRO costs", "label": "Accrued CRO costs" } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccruedLiabilitiesAndOtherLiabilities", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesSummaryOfAccruedAndOtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesSummaryOfAccruedAndOtherCurrentLiabilitiesDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued and other current liabilities", "label": "Accrued Liabilities and Other Liabilities", "totalLabel": "Total accrued and other liabilities" } } }, "auth_ref": [] }, "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccruedProfessionalFeesCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesSummaryOfAccruedAndOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesSummaryOfAccruedAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued professional services", "label": "Accrued Professional Fees" } } }, "auth_ref": [] }, "acet_AccruedResearchAndDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AccruedResearchAndDevelopment", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued research and development", "label": "Accrued research and development", "documentation": "Accrued research and development" } } }, "auth_ref": [] }, "acet_AccruedResearchAndDevelopmentExpensesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AccruedResearchAndDevelopmentExpensesCurrent", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesSummaryOfAccruedAndOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesSummaryOfAccruedAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Research And Development Expenses Current", "documentation": "Accrued research and development expenses current.", "terseLabel": "Accrued other research and development expenses" } } }, "auth_ref": [] }, "acet_AccruedResearchAndDevelopmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AccruedResearchAndDevelopmentPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued CRO, CMO, and Research and Development Expenses", "label": "Accrued Research And Development Policy [Text Block]", "documentation": "Accrued research and development." } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance", "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance", "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total", "negatedLabel": "Less: Accumulated depreciation and amortization", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total", "terseLabel": "Accumulated other comprehensive income", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "verboseLabel": "Accumulated Other Comprehensive Income" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r50" ] }, "acet_AdditionalClosingLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AdditionalClosingLiability", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional closing liability", "label": "Additional Closing Liability", "documentation": "Additional closing liability." } } }, "auth_ref": [] }, "acet_AdditionalCommonStockNotSold": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AdditionalCommonStockNotSold", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Common Stock not sold", "label": "Additional Common Stock not sold", "documentation": "Additional Common Stock not sold" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance", "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance", "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital", "label": "Additional Paid-in Capital [Member]" } } }, "auth_ref": [] }, "acet_AdicetTherapeuticsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AdicetTherapeuticsIncMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adicet Therapeutics [Member]", "label": "Adicet Therapeutics Inc [Member]", "documentation": "Adicet Therapeutics, Inc Member" } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r63" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r63" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r63" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r63" ] }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Standards Update", "label": "Accounting Standards Update [Axis]" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total", "terseLabel": "Stock-based compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Stock issuance cost", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" ], "lang": { "en-us": { "role": { "label": "Adjustments to Additional Paid in Capital, Warrant Issued", "terseLabel": "Underwritten public offering, net of issuance costs" } } }, "auth_ref": [] }, "us-gaap_AdministrativeFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdministrativeFeesExpense", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Administrative Fees", "label": "Administrative Fees Expense" } } }, "auth_ref": [] }, "acet_AdvisoryServicesAnnualFee": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AdvisoryServicesAnnualFee", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Advisory services annual fee", "label": "Advisory Services Annual Fee", "documentation": "Advisory services annual fee." } } }, "auth_ref": [] }, "acet_AggregateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AggregateFairValue", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Fair Value", "documentation": "Aggregate Fair Value" } } }, "auth_ref": [] }, "acet_AggregateNetProceed": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AggregateNetProceed", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Aggregate Net Proceed", "label": "Aggregate Net Proceed", "terseLabel": "aggregate net proceed" } } }, "auth_ref": [] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]", "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table" } } }, "auth_ref": [ "r108" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r21", "r32", "r42", "r75" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r24", "r35", "r45", "r78" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Pension Adjustments Service Cost [Member]", "terseLabel": "Aggregate Pension Adjustments Service Cost" } } }, "auth_ref": [ "r109" ] }, "acet_AgreementTransactionPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AgreementTransactionPrice", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Agreement transaction price", "label": "Agreement transaction price" } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r63" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r70" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r25", "r36", "r46", "r70", "r79", "r83", "r91" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r89" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total stock-based compensation expense", "terseLabel": "Expense related to options granted", "label": "Share-Based Payment Arrangement, Expense" } } }, "auth_ref": [] }, "acet_AmendedSalesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AmendedSalesAgreementMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Amended Sales Agreement [Member]", "documentation": "Amended Sales Agreement [Member]" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentDescription", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "terseLabel": "Amendment description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "acet_AmountPayableUponClosingOfMerger": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AmountPayableUponClosingOfMerger", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payable upon closing of merger", "label": "Amount Payable Upon Closing Of Merger", "documentation": "Amount payable upon closing of merger." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive securities excluded from computation of earnings per share", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities", "label": "Antidilutive Securities [Axis]" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name", "label": "Antidilutive Securities, Name [Domain]" } } }, "auth_ref": [] }, "acet_AreaOfSublease": { "xbrltype": "areaItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AreaOfSublease", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Area of Sublease", "documentation": "Area of Sublease", "terseLabel": "Area of Sublease" } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "auth_ref": [] }, "us-gaap_AssetBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetBackedSecuritiesMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Backed Securities", "label": "Asset-Backed Securities [Member]" } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Assets, Fair Value Disclosure, Total", "terseLabel": "Total fair value of assets", "label": "Assets, Fair Value Disclosure" } } }, "auth_ref": [] }, "acet_AtTheMarketOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AtTheMarketOfferingMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "At The Market Offering [Member]", "label": "At The Market Offering [Member]", "documentation": "At the market offering Member." } } }, "auth_ref": [] }, "acet_AtTheMarketOfferingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AtTheMarketOfferingTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtMarketATMOffering" ], "lang": { "en-us": { "role": { "terseLabel": "At-the-Market (ATM) Offering", "label": "At The Market Offering [Text Block]", "documentation": "At the market offering." } } }, "auth_ref": [] }, "acet_AtmProgramMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AtmProgramMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "ATM Program [Member]", "label": "ATM Program [Member]", "terseLabel": "ATM Program [Member]" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorFirmId", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r4", "r5", "r28" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorLocation", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "auth_ref": [ "r4", "r5", "r28" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorName", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "auth_ref": [ "r4", "r5", "r28" ] }, "dei_AuditorOpinionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorOpinionTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Opinion [Text Block]", "terseLabel": "Auditor Opinion" } } }, "auth_ref": [ "r112" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Gains", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Unrealized Losses", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Amortized Cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AvailableForSaleSecuritiesDebtSecurities", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Debt Securities, Available-for-sale, Total", "verboseLabel": "Total, Fair Value", "label": "Debt Securities, Available-for-Sale", "terseLabel": "Fair Value" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesSummaryOfClassificationOfMarketableDebtSecuritiesInConsolidatedBalanceSheetsDetails": { "parentTag": "us-gaap_MarketableSecurities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesSummaryOfClassificationOfMarketableDebtSecuritiesInConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Debt Securities, Available-for-sale, Current, Total", "terseLabel": "Short-term marketable debt securities", "label": "Debt Securities, Available-for-Sale, Current" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesSummaryOfClassificationOfMarketableDebtSecuritiesInConsolidatedBalanceSheetsDetails": { "parentTag": "us-gaap_MarketableSecurities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesSummaryOfClassificationOfMarketableDebtSecuritiesInConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term marketable debt securities", "label": "Debt Securities, Available-for-Sale, Noncurrent" } } }, "auth_ref": [] }, "acet_AvailableUnderTheLoanAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "AvailableUnderTheLoanAgreement", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Available under the Loan Agreement", "label": "Available under the Loan Agreement" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r86" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r87" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r82" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r82" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r82" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r82" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r82" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r82" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AwardTypeAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "auth_ref": [] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r85" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r84" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r83" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r83" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsSummaryOfChangeInCompanysContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location", "label": "Statement of Financial Position Location, Balance [Axis]" } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsSummaryOfChangeInCompanysContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location", "label": "Statement of Financial Position Location, Balance [Domain]" } } }, "auth_ref": [] }, "acet_BancOfCaliforniaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "BancOfCaliforniaMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Banc of California [Member]", "label": "Banc of California [Member]", "terseLabel": "Banc of California" } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "acet_BlackScholesOptionPricingModelMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "BlackScholesOptionPricingModelMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Black-Scholes Option-Pricing Model [Member]", "label": "Black-Scholes Option-Pricing Model [Member]", "terseLabel": "Black Scholes Option Pricing Model [Member]" } } }, "auth_ref": [] }, "acet_BostonMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "BostonMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureRestrictedCashRestrictedCashOnTheCompanysConsolidatedBalanceSheetsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfWeightedAverageIBRAndRemainingLeaseTermDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Boston, MA", "terseLabel": "Boston, Massachusetts [Member]", "label": "Boston [Member]", "documentation": "Boston [member]." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyParentheticalDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree", "label": "Business Combination [Domain]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyParentheticalDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition", "label": "Business Combination [Axis]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of the combined company owned by resTORbio stockholders", "label": "Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyParentheticalDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Combination [Line Items]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Supplemental Unaudited Pro Forma Information", "label": "Business Combination, Pro Forma Information, Nonrecurring Adjustment [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionProFormaInformationTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Summarizes the Purchase Price in the Merger", "label": "Business Combination, Pro Forma Information [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionSharePrice", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Multiplied by the fair value per share of resTORbio common stock", "label": "Business Combination, Price Per Share" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSupplementalUnauditedProFormaInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss", "label": "Business Combination, Pro Forma Information, Pro Forma Income (Loss), after Tax" } } }, "auth_ref": [] }, "acet_BusinessAcquisitionsProFormaRevenue1": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "BusinessAcquisitionsProFormaRevenue1", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSupplementalUnauditedProFormaInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue - related party", "label": "Business Acquisitions Pro Forma Revenue1", "documentation": "The pro forma revenues for a period as if the business combination or combinations had been completed at the beginning of the period." } } }, "auth_ref": [] }, "acet_BusinessCombinationAccelerationOfRestrictedStockUnitsUponMerger": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "BusinessCombinationAccelerationOfRestrictedStockUnitsUponMerger", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acceleration of restricted stock units upon merger", "label": "Business Combination Acceleration Of Restricted Stock Units Upon Merger", "documentation": "Business combination acceleration of restricted stock units upon merger." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction cost for business acquisition", "label": "Business Combination, Acquisition-Related Cost, Expense" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationAssetsArisingFromContingenciesAmountRecognized", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureBusinessCombinationScheduleOfChangesInTheCompanysIprdAndCvrSinceTheMergerDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Contingency Recognized at Acquisition Date, Asset Acquired, Fair Value", "terseLabel": "Fair value" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Business Combination, Consideration Transferred, Total", "terseLabel": "Purchase price", "label": "Business Combination, Consideration Transferred" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Business Combination, Contingent Consideration, Liability, Total", "terseLabel": "Contingent consideration liability", "label": "Business Combination, Contingent Consideration, Liability" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombination" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination", "label": "Business Combination [Text Block]" } } }, "auth_ref": [] }, "acet_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentTangibleAndIntangiblesAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentTangibleAndIntangiblesAssets", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement prior adjustment in tangible and intangible assets", "label": "Business Combination Provisional Information Initial Accounting Incomplete Adjustment Tangible And Intangibles Assets", "documentation": "Business combination provisional information initial accounting incomplete adjustment tangible and intangibles assets." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Business Combination, Recognized Asset Acquired, Prepaid Expense and Other Asset, Current" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts payable", "label": "Business Combination, Recognized Liability Assumed, Accounts Payable, Current" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accrued and other current liabilities", "label": "Business Combination, Recognized Liability Assumed, Other Liability, Current" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred tax liability", "label": "Business Combination, Recognized Liability Assumed, Deferred Tax Liability" } } }, "auth_ref": [] }, "acet_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInProcessResearchAndDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInProcessResearchAndDevelopment", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "IPR&D", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed In Process Research And Development", "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed in process research and development." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net assets acquired:", "label": "Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other liabilities", "label": "Business Combination, Recognized Liability Assumed, Other Liability, Noncurrent" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment", "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment, Total", "label": "Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment" } } }, "auth_ref": [] }, "acet_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Restricted Cash", "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed restricted cash." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Purchase price", "label": "Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination, Separately Recognized Transactions", "label": "Business Combination, Separately Recognized Transaction [Axis]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationSeparatelyRecognizedTransactionsDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination, Separately Recognized Transactions", "label": "Business Combination, Separately Recognized Transaction [Domain]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationTables" ], "lang": { "en-us": { "role": { "label": "Business Combination, Separately Recognized Transaction [Table Text Block]", "terseLabel": "Schedule of changes in the Company's IPR&D and CVR since the Merger" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition date fair value of resTORbio common shares", "label": "Business Combination, Achieved in Stages, Preacquisition Equity Interest in Acquiree, Fair Value" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of outstanding capital stock", "label": "Business Combination, Achieved in Stages, Preacquisition Equity Interest in Acquiree, Percentage" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationsAbstract", "lang": { "en-us": { "role": { "label": "Business Combination [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination", "label": "Business Combination [Policy Text Block]" } } }, "auth_ref": [] }, "acet_COVID19Member": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "COVID19Member", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "COVID-19", "terseLabel": "C O V I D19", "label": "C O V I D19 [Member]", "documentation": "COVID 19." } } }, "auth_ref": [] }, "acet_CaliforniaResearchAndDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "CaliforniaResearchAndDevelopmentMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "California Research And Development", "label": "California Research And Development [Member]", "documentation": "California research and development." } } }, "auth_ref": [] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Cash", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Cash, Ending Balance", "periodStartLabel": "Cash, Beginning Balance", "terseLabel": "Cash payment", "label": "Cash" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance", "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total", "terseLabel": "Cash and cash equivalents", "periodEndLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalent" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents [Axis]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Cash", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsAndShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsAndShortTermInvestments", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Cash, Cash Equivalents, and Short-term Investments, Total", "terseLabel": "Cash, cash equivalents and marketable securities", "label": "Cash, Cash Equivalents, and Short-Term Investments" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation", "periodEndLabel": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Ending Balance", "periodStartLabel": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Beginning Balance", "totalLabel": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Total" } } }, "auth_ref": [] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash, insured amount", "label": "Cash, FDIC Insured Amount" } } }, "auth_ref": [] }, "us-gaap_ChangeDuringPeriodFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ChangeDuringPeriodFairValueDisclosureMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureBusinessCombinationScheduleOfChangesInTheCompanysIprdAndCvrSinceTheMergerDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measure of Changes in Fair Value", "label": "Changes Measurement [Member]" } } }, "auth_ref": [] }, "acet_ChangeInFairValueIncludedInResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ChangeInFairValueIncludedInResearchAndDevelopmentExpense", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in the fair value included in research and development expense", "label": "Change In Fair Value Included In Research And Development Expense", "documentation": "Change in fair value included in research and development expense." } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r61" ] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]", "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year" } } }, "auth_ref": [ "r58" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]", "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested" } } }, "auth_ref": [ "r56" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfStockDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfStockLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class Of Stock [Line Items]", "label": "Class of Stock [Line Items]" } } }, "auth_ref": [] }, "acet_ClassOfWarrantExercised": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ClassOfWarrantExercised", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of warrants, exercised.", "label": "Class Of Warrant Exercised", "terseLabel": "Number of warrants, Exercised", "verboseLabel": "Weighted-Average Exercise Price, Options exercised" } } }, "auth_ref": [] }, "acet_ClassOfWarrantForfeited": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ClassOfWarrantForfeited", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Class Of Warrant Forfeited", "documentation": "Class Of Warrant Forfeited", "terseLabel": "Number of shares of common stock issuable, Forfeited" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "verboseLabel": "Class of Warrant or Right, Exercise Price of Warrants or Rights" } } }, "auth_ref": [] }, "acet_ClassOfWarrantOrRightIssued": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ClassOfWarrantOrRightIssued", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of warrants, Issued", "label": "Class Of Warrant Or Right Issued", "documentation": "Class Of Warrant Or Right Issued", "verboseLabel": "Number of shares of common stock issuable, Issued" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class Of Warrant Or Right [Line Items]", "label": "Class of Warrant or Right [Line Items]" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of securities called", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "verboseLabel": "Issuance of shares of common stock" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of Shares of Common Stock Issuable", "terseLabel": "Warrants outstanding", "label": "Class of Warrant or Right, Outstanding", "periodEndLabel": "Outstanding, December 31, 2025", "periodStartLabel": "Outstanding, December 31, 2024" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class Of Warrant Or Right [Table]", "label": "Class of Warrant or Right [Table]" } } }, "auth_ref": [] }, "acet_ClassOfWarrantOutstandingAndExercisableToPurchaseCommonStock": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ClassOfWarrantOutstandingAndExercisableToPurchaseCommonStock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class Of Warrant Outstanding And Exercisable To Purchase Common Stock", "periodEndLabel": "Number of warrants, Outstanding and exercisable to purchase common stock as of December 31, 2021", "documentation": "Class Of Warrant Outstanding And Exercisable To Purchase Common Stock" } } }, "auth_ref": [] }, "acet_ClassOfWarrantOutstandingAndExercisableToPurchasePreferredShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ClassOfWarrantOutstandingAndExercisableToPurchasePreferredShares", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of warrants, Outstanding and exercisable to purchase preferred shares", "label": "Class Of Warrant Outstanding And Exercisable To Purchase Preferred Shares", "periodStartLabel": "Number of warrants, Outstanding and exercisable to purchase preferred shares as of December 31, 2020", "documentation": "Class Of Warrant Outstanding And Exercisable To Purchase Preferred Shares" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r62" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r62" ] }, "us-gaap_CollaborativeArrangementDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CollaborativeArrangementDisclosureTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreements" ], "lang": { "en-us": { "role": { "terseLabel": "Third Party Agreements", "label": "Collaborative Arrangement Disclosure [Text Block]" } } }, "auth_ref": [] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsSummaryOfChangeInCompanysContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "auth_ref": [] }, "acet_CombinedBalancesInDemandDepositAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "CombinedBalancesInDemandDepositAccounts", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Combined balances in demand deposit accounts", "label": "Combined balances in demand deposit accounts", "terseLabel": "Combined balances in demand deposit accounts" } } }, "auth_ref": [] }, "us-gaap_CommercialPaperMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommercialPaperMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial Paper", "label": "Commercial Paper [Member]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 10)" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentsAndContingences" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingences", "label": "Commitments and Contingencies Disclosure [Text Block]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingenciesPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent Consideration Liability (CVR)", "label": "Commitments and Contingencies, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of common stock reserved for future issuance", "label": "Common Stock, Capital Shares Reserved for Future Issuance" } } }, "auth_ref": [] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock dividends declared | $ / shares", "label": "Common Stock, Dividends, Per Share, Declared" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "acet_CommonStockNotSold": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "CommonStockNotSold", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock not sold", "label": "Common Stock not sold", "documentation": "Common Stock not sold" } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock shares issued, par value", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock price per share" } } }, "auth_ref": [] }, "acet_CommonStockPursuantToAtTheMarketOfferingNetOfIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "CommonStockPursuantToAtTheMarketOfferingNetOfIssuanceCosts", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "issuance of common stock pursuant to at-the-market offering, net of issuance costs of $1.6 million,value", "label": "Common Stock Pursuant To At The Market Offering Net Of Issuance Costs", "documentation": "Common Stock Pursuant To At The Market Offering Net Of Issuance Costs" } } }, "auth_ref": [] }, "acet_CommonStockPursuantToAtTheMarketOfferingNetOfIssuanceCostsShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "CommonStockPursuantToAtTheMarketOfferingNetOfIssuanceCostsShares", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock pursuant to at-the-market offering, net of issuance costs of $1.6 million,shares", "label": "common stock pursuant to at-the-market offering, net of issuance costs,shares", "documentation": "common stock pursuant to at-the-market offering, net of issuance costs,shares" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized", "label": "Common Stock, Shares Authorized" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "totalLabel": "Common Stock, Shares, Issued, Total", "terseLabel": "Common stock, shares issued", "label": "Common Stock, Shares, Issued", "verboseLabel": "Issuance of common stock" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance", "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance", "terseLabel": "Common stock, shares outstanding", "label": "Common Stock, Shares, Outstanding" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesSubscribedButUnissued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesSubscribedButUnissued", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Subscribed but Unissued", "terseLabel": "Common Stock, Shares Subscribed but Unissued" } } }, "auth_ref": [] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock issued", "periodEndLabel": "Common Stock, Value, Issued, Ending Balance", "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance", "totalLabel": "Common Stock, Value, Issued, Total", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.0001 par value, 300,000,000 shares authorized as of December 31, 2025 and December 31, 2024, respectively; 9,586,770 and 5,160,545 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively" } } }, "auth_ref": [] }, "acet_CommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "CommonStockWarrantsMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock warrants issued and outstanding", "terseLabel": "Common Stock Warrants", "label": "Common Stock Warrants [Member]", "documentation": "Common stock warrants." } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r67" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r66" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r68" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r65" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Comprehensive Income (Loss)", "label": "Comprehensive Income, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComputerEquipmentMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Computer Equipment", "label": "Computer Equipment [Member]" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration of Credit Risk", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Principles of Consolidation", "label": "Consolidation, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_ConstructionInProgressGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConstructionInProgressGross", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Construction in Progress, Gross", "terseLabel": "Decrease in construction in progress" } } }, "auth_ref": [] }, "us-gaap_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConstructionInProgressMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Construction In Progress", "label": "Construction in Progress [Member]" } } }, "auth_ref": [] }, "acet_ConstructionInProgressNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ConstructionInProgressNet", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Construction in progress remaining", "documentation": "construction in progress net", "label": "construction in progress net" } } }, "auth_ref": [] }, "acet_ContingentConsiderationFees": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ContingentConsiderationFees", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Contingent Consideration fees", "label": "Contingent Consideration fees", "terseLabel": "Contingent Consideration, fees" } } }, "auth_ref": [] }, "acet_ContingentConsiderationLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ContingentConsiderationLiabilityMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent Consideration Liability", "label": "Contingent Consideration Liability [Member]", "documentation": "Contingent Consideration Liability." } } }, "auth_ref": [] }, "acet_ContingentConsiderationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ContingentConsiderationMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent Consideration [Member]", "label": "Contingent Consideration [Member]", "documentation": "Contingent Consideration" } } }, "auth_ref": [] }, "acet_ContingentValueRightsAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ContingentValueRightsAgreementMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureBusinessCombinationScheduleOfChangesInTheCompanysIprdAndCvrSinceTheMergerDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent Value Rights Agreement", "label": "Contingent Value Rights Agreement [Member]", "documentation": "Contingent value rights agreement [member]." } } }, "auth_ref": [] }, "acet_ContractAssetMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ContractAssetMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsSummaryOfChangeInCompanysContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract Asset", "label": "Contract Asset [Member]", "documentation": "Contract Asset." } } }, "auth_ref": [] }, "acet_ContractAssetsAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ContractAssetsAndLiabilities", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsSummaryOfChangeInCompanysContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning of period", "periodEndLabel": "Balance at end of period", "label": "Contract Assets And Liabilities", "documentation": "Contract assets and liabilities." } } }, "auth_ref": [] }, "acet_ContractAssetsAndLiabilitiesAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ContractAssetsAndLiabilitiesAdditions", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsSummaryOfChangeInCompanysContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additions", "label": "Contract Assets And Liabilities Additions", "documentation": "Contract assets and liabilities additions." } } }, "auth_ref": [] }, "acet_ContractAssetsAndLiabilitiesAdditionsDeductions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ContractAssetsAndLiabilitiesAdditionsDeductions", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsSummaryOfChangeInCompanysContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Additions (Deductions)", "label": "Contract Assets And Liabilities Additions Deductions", "documentation": "Contract assets and liabilities additions (deductions)." } } }, "auth_ref": [] }, "acet_ContractLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ContractLiability", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract liability", "label": "Contract Liability", "documentation": "Contract liability." } } }, "auth_ref": [] }, "acet_ContractLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ContractLiabilityMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsSummaryOfChangeInCompanysContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract Liability", "label": "Contract Liability [Member]", "documentation": "Contract liability." } } }, "auth_ref": [] }, "acet_ContractResearchTermPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ContractResearchTermPeriod", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract research term period", "label": "Contract Research Term Period", "documentation": "Contract research term period." } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Change in Company's Contract Liabilities", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in estimated transaction price", "label": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Revenue recognized" } } }, "auth_ref": [] }, "acet_ContractualContingentValueRight": { "xbrltype": "integerItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ContractualContingentValueRight", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Contractual Contingent Value Right", "documentation": "Contractual Contingent Value Right", "terseLabel": "Contractual Contingent Value Right" } } }, "auth_ref": [] }, "acet_ConversionOfConvertiblePreferredStockWarrantsIntoCommonStockWarrantsInConnectionWithMerger": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ConversionOfConvertiblePreferredStockWarrantsIntoCommonStockWarrantsInConnectionWithMerger", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of convertible preferred stock warrant into common stock warrant in connection with Merger", "label": "Conversion Of Convertible Preferred Stock Warrants Into Common Stock Warrants In Connection With Merger", "documentation": "Conversion of convertible preferred stock warrants into common stock warrants in connection with merger." } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockAmountConverted1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConversionOfStockAmountConverted1", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of redeemable convertible preferred stock warrants to common stock warrants", "label": "Conversion of Stock, Amount Converted" } } }, "auth_ref": [] }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of common stock shares issued upon conversion", "terseLabel": "Common Stock Issued Upon Conversion (1)", "label": "Convertible Preferred Stock, Shares Issued upon Conversion" } } }, "auth_ref": [] }, "acet_CorporateCreditCardServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "CorporateCreditCardServicesMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureRestrictedCashRestrictedCashOnTheCompanysConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "label": "Corporate credit card services [Member]", "documentation": "Corporate credit card services [Member]" } } }, "auth_ref": [] }, "us-gaap_CorporateDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CorporateDebtSecuritiesMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate Debt Securities", "label": "Corporate Debt Securities [Member]" } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Current:", "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Federal", "label": "Current Federal Tax Expense (Benefit)" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CurrentForeignTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Current Foreign Tax Expense (Benefit)" } } }, "auth_ref": [] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Total current", "label": "Current Income Tax Expense (Benefit)" } } }, "auth_ref": [] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "State", "label": "Current State and Local Tax Expense (Benefit)" } } }, "auth_ref": [] }, "acet_CustomersPercentageOfTotalRevenue": { "xbrltype": "percentItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "CustomersPercentageOfTotalRevenue", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customers percentage of total revenue", "label": "Customers Percentage Of Total Revenue", "documentation": "Customers percentage of total revenue." } } }, "auth_ref": [] }, "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r13", "r102" ] }, "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]" } } }, "auth_ref": [ "r13", "r102" ] }, "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]" } } }, "auth_ref": [ "r15", "r104" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]" } } }, "auth_ref": [ "r15", "r104" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]" } } }, "auth_ref": [ "r17", "r106" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]" } } }, "auth_ref": [ "r15", "r104" ] }, "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]" } } }, "auth_ref": [ "r8", "r97" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementProcessesIntegratedFlag", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes Integrated [Flag]" } } }, "auth_ref": [ "r9", "r98" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes Integrated [Text Block]" } } }, "auth_ref": [ "r9", "r98" ] }, "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract", "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]" } } }, "auth_ref": [ "r7", "r96" ] }, "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]" } } }, "auth_ref": [ "r7", "r96" ] }, "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]" } } }, "auth_ref": [ "r7", "r96" ] }, "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Third Party Engaged [Flag]" } } }, "auth_ref": [ "r10", "r99" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]" } } }, "auth_ref": [ "r12", "r101" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]" } } }, "auth_ref": [ "r12", "r101" ] }, "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r13", "r102" ] }, "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]" } } }, "auth_ref": [ "r16", "r105" ] }, "cyd_CybersecurityRiskRoleOfManagementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskRoleOfManagementTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Role of Management [Text Block]" } } }, "auth_ref": [ "r14", "r103" ] }, "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]" } } }, "auth_ref": [ "r11", "r100" ] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoan" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan", "label": "Debt Disclosure [Text Block]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "label": "Debt Instrument, Basis Spread on Variable Rate" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Face Amount", "terseLabel": "Available Loan" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentMaturityDateRangeEnd1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentMaturityDateRangeEnd1", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loan availability end date", "label": "Debt Instrument, Maturity Date Range, End" } } }, "auth_ref": [] }, "us-gaap_DebtPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Debt, Policy [Policy Text Block]", "terseLabel": "Short-Term Investments" } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLoss", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for credit-related losses", "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss", "periodEndLabel": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Ending Balance", "periodStartLabel": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Beginning Balance", "totalLabel": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Total" } } }, "auth_ref": [] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Federal", "label": "Deferred Federal Income Tax Expense (Benefit)" } } }, "auth_ref": [] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred:", "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredFinanceCostsGross", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt issuance costs, gross", "label": "Debt Issuance Costs, Gross" } } }, "auth_ref": [] }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredForeignIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Deferred Foreign Income Tax Expense (Benefit)" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred", "label": "Deferred Income Tax Expense (Benefit)" } } }, "auth_ref": [] }, "acet_DeferredIncomeTaxesAndTaxCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "DeferredIncomeTaxesAndTaxCredit", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Income Taxes And Tax Credit", "documentation": "Deferred Income Taxes And Tax Credit", "terseLabel": "Tax credits" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredIncomeTaxesAndTaxCredits", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Income Taxes and Tax Credits, Total", "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Tax credits" } } }, "auth_ref": [] }, "us-gaap_DeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredRevenue", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Revenue, Total", "terseLabel": "Deferred Revenue", "label": "Deferred Revenue" } } }, "auth_ref": [] }, "us-gaap_DeferredRevenueRevenueRecognized1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredRevenueRevenueRecognized1", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue related party", "label": "Deferred Revenue, Revenue Recognized" } } }, "auth_ref": [] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "State", "label": "Deferred State and Local Income Tax Expense (Benefit)" } } }, "auth_ref": [] }, "acet_DeferredTaxAssetsFixedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "DeferredTaxAssetsFixedAssets", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Fixed Assets", "label": "Deferred Tax Assets Fixed Assets", "verboseLabel": "Fixed Assets" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets", "label": "Deferred Tax Assets, Goodwill and Intangible Assets" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross deferred tax assets", "label": "Deferred Tax Assets, Gross" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development credit carryforwards", "label": "Deferred Tax Asset, In-Process Research and Development" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net", "totalLabel": "Net deferred tax asset" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred tax assets, net of valuation allowance", "label": "Deferred Tax Assets, Net of Valuation Allowance" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsNetAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Tax Assets:", "label": "Deferred Tax Assets, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total", "terseLabel": "Net operating loss carryforwards", "label": "Deferred Tax Assets, Operating Loss Carryforwards" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Total", "terseLabel": "Accruals and reserves", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Tax Assets, Valuation Allowance, Total", "negatedLabel": "Less: Valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance" } } }, "auth_ref": [] }, "acet_DeferredTaxAssetsValuationAllowanceIncrease": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "DeferredTaxAssetsValuationAllowanceIncrease", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in valuation allowance", "label": "Deferred Tax Assets Valuation Allowance Increase", "documentation": "Deferred Tax Assets Valuation Allowance Increase." } } }, "auth_ref": [] }, "acet_DeferredTaxBasisDifferenceIPRD": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "DeferredTaxBasisDifferenceIPRD", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basis Difference IPR&D", "label": "Deferred Tax Basis Difference I P R D", "documentation": "Deferred tax basis difference IPR&D." } } }, "auth_ref": [] }, "acet_DeferredTaxFinanceLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "DeferredTaxFinanceLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Finance Lease Right Of Use Asset", "documentation": "Deferred Tax Finance Lease Right Of Use Asset", "terseLabel": "Finance lease right-of-use asset" } } }, "auth_ref": [] }, "acet_DeferredTaxFinanceLeaseRightOfUseAssetLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "DeferredTaxFinanceLeaseRightOfUseAssetLiability", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liability", "label": "Deferred Tax Finance Lease Right Of Use Asset Liability", "documentation": "Deferred Tax Finance Lease Right Of Use Asset Liability" } } }, "auth_ref": [] }, "acet_DeferredTaxLiabilitiesFixedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "DeferredTaxLiabilitiesFixedAssets", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Fixed assets", "label": "Deferred Tax Liabilities Fixed Assets", "documentation": "Deferred tax liabilities fixed assets" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilitiesNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxLiabilitiesNetAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities:", "label": "Deferred Tax Liabilities, Net [Abstract]" } } }, "auth_ref": [] }, "acet_DeferredTaxOperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "DeferredTaxOperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use asset", "label": "Deferred Tax Operating Lease Right Of Use Asset", "documentation": "Operating lease right-of-use asset." } } }, "auth_ref": [] }, "acet_DeferredTaxOperatingLeaseRightOfUseAssetLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "DeferredTaxOperatingLeaseRightOfUseAssetLiability", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use asset liability", "label": "Deferred Tax Operating Lease Right Of Use Asset Liability", "documentation": "Deferred tax operating lease right of use asset liability." } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureDefinedContributionPlanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount", "terseLabel": "Company contribution in the plan" } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedContributionPlanTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureDefinedContributionPlan" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Contribution Plan", "label": "Defined Contribution Plan [Text Block]" } } }, "auth_ref": [] }, "us-gaap_DemandDepositAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DemandDepositAccounts", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Demand Deposit Accounts", "terseLabel": "Demand Deposit Accounts" } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails": { "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation", "totalLabel": "Depreciation, Total", "terseLabel": "Depreciation" } } }, "auth_ref": [] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DepreciationAndAmortization", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Depreciation, Depletion and Amortization, Nonproduction, Total", "terseLabel": "Depreciation and amortization expense", "label": "Depreciation, Depletion and Amortization, Nonproduction" } } }, "auth_ref": [] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Contract [Domain]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "acet_DiscountOnUnderwritersWarrant": { "xbrltype": "percentItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "DiscountOnUnderwritersWarrant", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Discount On Underwriters Warrant", "label": "Discount On Underwriters Warrant", "terseLabel": "Discount On Under writers Warrant" } } }, "auth_ref": [] }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DividendsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends Payable", "label": "Dividends Payable" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAnnualReport", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Annual Report", "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r4", "r5", "r28" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "terseLabel": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r4", "r5", "r28", "r71" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentTransitionReport", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r49" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Documents Incorporated by Reference", "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r2" ] }, "us-gaap_DomesticCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DomesticCountryMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Domestic Tax Authority", "label": "Domestic Tax Jurisdiction [Member]" } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]", "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year" } } }, "auth_ref": [ "r60" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails", "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "totalLabel": "Earnings Per Share, Basic, Total", "terseLabel": "Net loss per share, basic" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails", "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "totalLabel": "Earnings Per Share, Diluted, Total", "terseLabel": "Net loss per share, diluted" } } }, "auth_ref": [] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss per Share" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Net Loss per Share", "label": "Earnings Per Share [Text Block]" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateContinuingOperations", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Provision for income taxes" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage", "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Federal statutory income tax rate, percent", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Change in valuation allowance, Percent" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Rate Differential", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent" } } }, "auth_ref": [] }, "acet_EffectiveIncomeTaxRateReconciliationGoodwillImpairment": { "xbrltype": "percentItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "EffectiveIncomeTaxRateReconciliationGoodwillImpairment", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill Impairment", "documentation": "Effective Income Tax Rate Reconciliation Goodwill Impairment", "label": "Effective Income Tax Rate Reconciliation Goodwill Impairment" } } }, "auth_ref": [] }, "acet_EffectiveIncomeTaxRateReconciliationNonDeductibleExpensePermanentDifferences": { "xbrltype": "percentItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "EffectiveIncomeTaxRateReconciliationNonDeductibleExpensePermanentDifferences", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation Non deductible Expense Permanent differences", "documentation": "Effective Income Tax Rate Reconciliation Non deductible Expense Permanent differences", "terseLabel": "Permanent differences" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Other, Percent", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent", "terseLabel": "Stock based compensation" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount", "terseLabel": "Stock based compensation, Amount" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent", "terseLabel": "Stock-based compensation, Percent" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State income taxes, Percent" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingenciesForeign": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationTaxContingenciesForeign", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign tax effects, Percent", "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Percent" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Tax credits, Percent", "totalLabel": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent, Total", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsForeign", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign tax effects", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsOther", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent", "terseLabel": "Other permanent differences, Percent" } } }, "auth_ref": [] }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeBenefitsAndShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Employee Benefits and Share-Based Compensation", "terseLabel": "Stock-based compensation recognized" } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesSummaryOfAccruedAndOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesSummaryOfAccruedAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Employee-related Liabilities, Current, Total", "terseLabel": "Accrued compensation", "label": "Employee-related Liabilities, Current" } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation expense, estimated weighted-average period for recognition", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition" } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation expense", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount" } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "verboseLabel": "Employee Stock Option" } } }, "auth_ref": [] }, "acet_EmployeeStockPurchasePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "EmployeeStockPurchasePlanMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Purchase Plan", "documentation": "Employee Stock Purchase Plan", "label": "Employee Stock Purchase Plan [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "acet_EntityDateOfMerger": { "xbrltype": "dateItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "EntityDateOfMerger", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity date of merger", "label": "Entity Date Of Merger", "documentation": "Entity date of merger." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Ex Transition Period", "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r114" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFilerCategory", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1" ] }, "dei_EntityIncorporationDateOfIncorporation": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationDateOfIncorporation", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity incorporation date", "label": "Entity Incorporation, Date of Incorporation", "documentation": "Date when an entity was incorporated" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r111" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Public Float", "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityShellCompany", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r1" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntitySmallBusiness", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Voluntary Filers", "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Well-known Seasoned Issuer", "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r113" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments, Footnote [Text Block]", "terseLabel": "Equity Awards Adjustments, Footnote" } } }, "auth_ref": [ "r54" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]", "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table" } } }, "auth_ref": [ "r107" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments [Member]", "terseLabel": "Equity Awards Adjustments" } } }, "auth_ref": [ "r107" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]", "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table" } } }, "auth_ref": [ "r107" ] }, "us-gaap_EquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquipmentMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lab and computer equipment", "label": "Equipment [Member]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityComponentDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component", "label": "Equity Component [Domain]" } } }, "auth_ref": [] }, "us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityIssuedInBusinessCombinationFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of common stock shares of the combined company owned by resTORbio stockholders", "label": "Equity Issued in Business Combination, Fair Value Disclosure" } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investment, Ownership percentage", "label": "Equity Method Investment, Ownership Percentage" } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r64" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r21", "r32", "r42", "r75" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r18", "r29", "r39", "r72" ] }, "acet_EstimatedFairValueOfCVRLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "EstimatedFairValueOfCVRLiability", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated fair value of the CVR liability", "label": "Estimated Fair Value Of C V R Liability", "documentation": "Estimated fair value of CVR liability." } } }, "auth_ref": [] }, "acet_ExchangeRatio": { "xbrltype": "pureItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ExchangeRatio", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange ratio", "label": "Exchange Ratio", "documentation": "Exchange ratio." } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r70" ] }, "acet_ExerciseFeePaid": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ExerciseFeePaid", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Exercise fee paid.", "label": "Exercise Fee Paid", "terseLabel": "Exercise Fee Paid" } } }, "auth_ref": [] }, "acet_ExercisePriceOfOptionsPercentageOfFairMarketValueOfCommonStock": { "xbrltype": "percentItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ExercisePriceOfOptionsPercentageOfFairMarketValueOfCommonStock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Of Options Percentage Of Fair Market Value Of Common Stock", "documentation": "Exercise Price Of Options Percentage Of Fair Market Value Of Common Stock" } } }, "auth_ref": [] }, "acet_ExercisedInvestmentRightAndPurchased": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ExercisedInvestmentRightAndPurchased", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Exercised Investment Right and Purchased", "documentation": "Exercised Investment Right and Purchased", "terseLabel": "Exercised Investment Right and Purchased" } } }, "auth_ref": [] }, "acet_ExternalProgramExpensesForProductCandidatesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ExternalProgramExpensesForProductCandidatesAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "External program expenses for product candidates", "label": "External Program Expenses For Product Candidates [Abstract]", "documentation": "External Program Expenses For Product Candidates [Abstract]" } } }, "auth_ref": [] }, "acet_FacilitiesAndInfrastructureExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "FacilitiesAndInfrastructureExpenses", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails": { "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Facilities and Infrastructure Expenses", "documentation": "Facilities and Infrastructure Expenses", "terseLabel": "Facilities and infrastructure expenses" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "auth_ref": [] }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureBusinessCombinationScheduleOfChangesInTheCompanysIprdAndCvrSinceTheMergerDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "auth_ref": [] }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByBalanceSheetGroupingTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureBusinessCombinationScheduleOfChangesInTheCompanysIprdAndCvrSinceTheMergerDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "auth_ref": [] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "auth_ref": [] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureBusinessCombinationScheduleOfChangesInTheCompanysIprdAndCvrSinceTheMergerDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Basis", "label": "Measurement Basis [Axis]" } } }, "auth_ref": [] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency", "label": "Measurement Frequency [Axis]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueDisclosureItemAmountsDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureBusinessCombinationScheduleOfChangesInTheCompanysIprdAndCvrSinceTheMergerDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurement", "label": "Fair Value Measurement [Domain]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Disclosures [Text Block]" } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Level 1", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Level 2", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Level 3", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency", "label": "Measurement Frequency [Domain]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Financial Instruments", "label": "Fair Value Measurement, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in the fair value included in other income (expense), net", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Recurring [Member]", "label": "Fair Value, Recurring [Member]" } } }, "auth_ref": [] }, "acet_FairValueOfCommonStockPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "FairValueOfCommonStockPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Common Stock", "label": "Fair Value Of Common Stock Policy [Text Block]", "documentation": "Fair value of common stock." } } }, "auth_ref": [] }, "acet_FairValueOfModifiedStockOptionsAndRestrictedStockUnitsAttributableToPreCombinationServices": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "FairValueOfModifiedStockOptionsAndRestrictedStockUnitsAttributableToPreCombinationServices", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated fair value of modified stock options and restricted stock units attributable to pre-combination services", "label": "Fair Value Of Modified Stock Options And Restricted Stock Units Attributable To Pre Combination Services", "documentation": "Fair value of modified stock options and restricted stock units attributable to pre-combination services." } } }, "auth_ref": [] }, "acet_FederalAndStateResearchAndDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "FederalAndStateResearchAndDevelopmentMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Federal and state research and development [Member]", "label": "Federal and state research and development [Member]" } } }, "auth_ref": [] }, "acet_FeesAndExpenseIncurredInConnectionWithClinicalTrials": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "FeesAndExpenseIncurredInConnectionWithClinicalTrials", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total fees and expenses related to clinical trials", "label": "Fees And Expense Incurred In Connection With Clinical Trials", "documentation": "Fees and expense incurred in connection with clinical trials." } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseInterestExpense", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest on lease liabilities", "label": "Finance Lease, Interest Expense" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilitiesPaymentsRollingMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilitiesPaymentsRollingMaturityAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid, Rolling Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiability", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease liability", "label": "Finance Lease, Liability", "totalLabel": "Total lease liability" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease liability", "label": "Finance Lease, Liability, Current", "negatedLabel": "Less: current portion" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Finance lease liability, net of current portion" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityPaymentsDue", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid", "totalLabel": "Total undiscounted lease payments" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Finance Lease, Liability, to be Paid, Next Rolling 12 Months" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid, after Rolling Year Five", "terseLabel": "2031 and thereafter" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueInRollingYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityPaymentsDueInRollingYearFive", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2030", "label": "Finance Lease, Liability, to be Paid, Rolling Year Five" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueInRollingYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityPaymentsDueInRollingYearFour", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid, Rolling Year Four", "terseLabel": "2029" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueInRollingYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityPaymentsDueInRollingYearThree", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Finance Lease, Liability, to be Paid, Rolling Year Three" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueInRollingYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityPaymentsDueInRollingYearTwo", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid, Rolling Year Two", "terseLabel": "2027" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: imputed interest", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less: imputed interest" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "totalLabel": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total", "terseLabel": "Finance lease right-of-use asset" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseRightOfUseAssetAmortization", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Amortization of right-of-use assets" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted-average discount rate - finance leases" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average remaining lease term - finance leases (in years)", "label": "Finance Lease, Weighted Average Remaining Lease Term" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instrument", "label": "Financial Instrument [Axis]" } } }, "auth_ref": [] }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancialLiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Financial Liabilities Fair Value Disclosure, Total", "periodStartLabel": "Fair value, beginning balance", "periodEndLabel": "Fair value, ending balance", "label": "Financial Liabilities Fair Value Disclosure" } } }, "auth_ref": [] }, "acet_FinancingLeaseProceedsPaymentsUse": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "FinancingLeaseProceedsPaymentsUse", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails" ], "lang": { "en-us": { "role": { "label": "Financing Lease Proceeds Payments Use", "documentation": "Financing Lease Proceeds Payments Use", "terseLabel": "Financing cash flows used for finance lease liabilities", "negatedLabel": "Financing cash flows used for finance lease liabilities" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureBusinessCombinationScheduleOfChangesInTheCompanysIprdAndCvrSinceTheMergerDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureBusinessCombinationScheduleOfChangesInTheCompanysIprdAndCvrSinceTheMergerDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "auth_ref": [] }, "us-gaap_ForeignCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ForeignCountryMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Tax Authority", "label": "Foreign Tax Jurisdiction [Member]" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r25", "r36", "r46", "r79" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r25", "r36", "r46", "r79" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r25", "r36", "r46", "r79" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r25", "r36", "r46", "r79" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r25", "r36", "r46", "r79" ] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]", "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year" } } }, "auth_ref": [ "r59" ] }, "acet_FrancescoGalimiMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "FrancescoGalimiMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Francesco Galimi [Member]", "documentation": "Francesco Galimi [Member]", "terseLabel": "Francesco Galimi" } } }, "auth_ref": [] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Furniture and Fixtures", "label": "Furniture and Fixtures [Member]" } } }, "auth_ref": [] }, "acet_GainLossFromTheRemeasurementOfRedeemableConvertiblePreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "GainLossFromTheRemeasurementOfRedeemableConvertiblePreferredStock", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain from the remeasurement of the redeemable convertible preferred stock", "label": "Gain Loss From The Remeasurement Of Redeemable Convertible Preferred Stock", "documentation": "Gain (loss) from the remeasurement of the redeemable convertible preferred stock." } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "General and Administrative Expense, Total", "terseLabel": "General and administrative", "label": "General and Administrative Expense" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GeneralAndAdministrativeExpenseMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General and Administrative", "label": "General and Administrative Expense [Member]" } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Goodwill, Ending Balance", "periodStartLabel": "Goodwill, Beginning Balance", "totalLabel": "Goodwill, Total", "terseLabel": "Goodwill", "label": "Goodwill" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureGoodwill" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill and Intangible Assets Disclosure [Text Block]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets", "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill, Impaired, Accumulated Impairment Loss", "terseLabel": "Goodwill Impairement charges" } } }, "auth_ref": [] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill impairment", "label": "Goodwill, Impairment Loss" } } }, "auth_ref": [] }, "acet_GrantTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "GrantTerm", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grant term", "label": "Grant Term", "documentation": "Grant term." } } }, "auth_ref": [] }, "us-gaap_GrantsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GrantsReceivable", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grants receivable", "label": "Grants Receivable" } } }, "auth_ref": [] }, "us-gaap_IPOMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IPOMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial Public Offering", "label": "IPO [Member]" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "ICFR Auditor Attestation Flag", "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r4", "r5", "r28" ] }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment charges", "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of Long-Lived Assets", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_InProcessResearchAndDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InProcessResearchAndDevelopmentMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureBusinessCombinationScheduleOfChangesInTheCompanysIprdAndCvrSinceTheMergerDetails" ], "lang": { "en-us": { "role": { "label": "In Process Research and Development [Member]", "terseLabel": "In Process Research and Development" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Loss before income tax provision (benefit)", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before income tax provision" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location", "label": "Statement of Income Location, Balance [Axis]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location", "label": "Statement of Income Location, Balance [Domain]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority", "label": "Income Tax Jurisdiction [Axis]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority", "label": "Income Tax Jurisdiction [Domain]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 0.0 }, "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails": { "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0, "order": 9.0 }, "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForBenefitFromIncomeTaxesDetail", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail", "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax provision", "totalLabel": "Provision for income taxes" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Amount", "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Change in valuation allowance, Amount", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "terseLabel": "Foreign rate differential, Amount" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Federal statutory income tax rate, Amount", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount" } } }, "auth_ref": [] }, "acet_IncomeTaxReconciliationNonDeductibleExpensePermanentDifferences": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "IncomeTaxReconciliationNonDeductibleExpensePermanentDifferences", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Income Tax Reconciliation Non deductible Expense Permanent differences", "documentation": "Income Tax Reconciliation Non deductible Expense Permanent differences", "terseLabel": "Permanent differences" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationNondeductibleExpenseOther", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount", "terseLabel": "Other" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount", "terseLabel": "Stock based compensation" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationOtherAdjustments", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "terseLabel": "State income taxes, Amount" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationTaxCredits", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount", "totalLabel": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount, Total", "terseLabel": "Tax credits, Amount" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationTaxCreditsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationTaxCreditsOther", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Other permanent differences, Amount", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationTaxSettlementsForeign": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationTaxSettlementsForeign", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Amount", "terseLabel": "Foreign tax effects, Amount" } } }, "auth_ref": [] }, "acet_IncomeTaxesDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "IncomeTaxesDisclosureLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Income taxes disclosure.", "terseLabel": "Income Taxes Disclosure [Line Items]", "label": "Income Taxes Disclosure [Line Items]" } } }, "auth_ref": [] }, "acet_IncomeTaxesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "IncomeTaxesTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes [Table]", "label": "Income Taxes [Table]", "documentation": "Income taxes." } } }, "auth_ref": [] }, "acet_IncreaseDecreaseInEstimatedFairValueOfCvrLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "IncreaseDecreaseInEstimatedFairValueOfCvrLiability", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase decrease in estimated fair value of CVR liability", "label": "Increase Decrease In Estimated Fair Value Of Cvr Liability", "documentation": "Increase decrease in estimated fair value of cvr liability." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r25", "r36", "r46", "r70", "r79", "r83", "r91" ] }, "acet_InducementGrantMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "InducementGrantMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Inducement Grant.", "label": "Inducement Grant [Member]", "terseLabel": "Inducement Grant" } } }, "auth_ref": [] }, "acet_InducementGrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "InducementGrantsMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2018 Employee Stock Purchase Plan", "label": "Inducement Grants [Member]", "documentation": "Inducement grants member." } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r89" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r6", "r95" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r6", "r95" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r6", "r95" ] }, "us-gaap_IntellectualPropertyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IntellectualPropertyMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intellectual Property", "label": "Intellectual Property [Member]" } } }, "auth_ref": [] }, "us-gaap_InterestAndOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestAndOtherIncome", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Interest and Other Income, Total", "terseLabel": "Interest income", "label": "Interest and Other Income" } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Interest Expense, Total", "negatedLabel": "Interest expense", "label": "Interest Expense, Operating and Nonoperating" } } }, "auth_ref": [] }, "us-gaap_InterestIncomeOperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestIncomeOperating", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails": { "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Interest Income, Operating", "totalLabel": "Interest Income, Operating, Total", "negatedLabel": "Interest income" } } }, "auth_ref": [] }, "us-gaap_InterestReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestReceivableCurrent", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest receivable", "label": "Interest Receivable, Current" } } }, "auth_ref": [] }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecurities" ], "lang": { "en-us": { "role": { "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "terseLabel": "Marketable Securities" } } }, "auth_ref": [] }, "acet_IssuanceOfCommonStockFromAtmOfferingNetOfSalesAgentCommissionAndFeesAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "IssuanceOfCommonStockFromAtmOfferingNetOfSalesAgentCommissionAndFeesAmount", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Issuance Of Common Stock From Atm Offering Net Of Sales Agent Commission And Fees Amount", "documentation": "Issuance Of Common Stock From Atm Offering Net Of Sales Agent Commission And Fees Amount", "terseLabel": "Issuance of common stock and pre-funded warrants pursuant to underwritten public offering, net of issuance costs of $6.3 million" } } }, "auth_ref": [] }, "acet_IssuanceOfCommonStockFromAtmOfferingNetOfSalesAgentCommissionAndFeesShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "IssuanceOfCommonStockFromAtmOfferingNetOfSalesAgentCommissionAndFeesShares", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Issuance Of Common Stock From Atm Offering Net Of Sales Agent Commission And Fees Shares", "documentation": "Issuance Of Common Stock From Atm Offering Net Of Sales Agent Commission And Fees Shares", "terseLabel": "Issuance of common stock and pre-funded warrants pursuant to underwritten public offering, net of issuance costs of $6.3 million, Shares" } } }, "auth_ref": [] }, "acet_JefferiesLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "JefferiesLlcMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Jefferies LLC [Member]", "label": "Jefferies LLC [Member]", "terseLabel": "Jefferies LLC [Member]" } } }, "auth_ref": [] }, "acet_LaboratoryEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LaboratoryEquipmentMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Laboratory Equipment", "label": "Laboratory Equipment [Member]", "documentation": "Laboratory Equipment Member" } } }, "auth_ref": [] }, "us-gaap_LeaseContractualTermAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeaseContractualTermAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfWeightedAverageIBRAndRemainingLeaseTermDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease Contractual Term", "label": "Lease Contractual Term [Axis]" } } }, "auth_ref": [] }, "us-gaap_LeaseContractualTermDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeaseContractualTermDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfWeightedAverageIBRAndRemainingLeaseTermDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease Contractual Term", "label": "Lease Contractual Term [Domain]" } } }, "auth_ref": [] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease cost", "label": "Lease, Cost" } } }, "auth_ref": [] }, "us-gaap_LeaseCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeaseCostAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease Cost", "label": "Lease, Cost [Abstract]" } } }, "auth_ref": [] }, "acet_LeaseCostOtherInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LeaseCostOtherInformationAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Information", "label": "Lease Cost Other Information [Abstract]", "documentation": "Lease cost other information." } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentsAndContingencesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Lease Costs and Other Information", "label": "Lease, Cost [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leasehold Improvements", "label": "Leasehold Improvements [Member]" } } }, "auth_ref": [] }, "us-gaap_LegalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LegalFees", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal fees", "label": "Legal Fees" } } }, "auth_ref": [] }, "acet_LessPortionOfFairValueToBeDistributedAsCVR": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LessPortionOfFairValueToBeDistributedAsCVR", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less: portion of the fair value to be distributed as CVR", "label": "Less Portion Of Fair Value To Be Distributed As C V R", "documentation": "Less portion of the fair value to be distributed as CVR." } } }, "auth_ref": [] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Leases [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentsAndContingencesTables" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "terseLabel": "Schedule Of Future Lease payments" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total undiscounted lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, after Rolling Year Five", "terseLabel": "2031 and thereafter" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Rolling Year Five", "terseLabel": "2030" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Rolling Year Four", "terseLabel": "2029" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Rolling Year Three", "terseLabel": "2028" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Rolling Year Two", "terseLabel": "2027" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Next Rolling 12 Months", "terseLabel": "2026" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails2": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less: imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders' equity", "label": "Liabilities and Equity" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities, redeemable convertible preferred stock, and stockholders\u2019 equity (deficit)", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesFairValueAdjustment", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Settlement", "label": "Liabilities, Fair Value Adjustment" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Liabilities, Fair Value Disclosure, Total", "terseLabel": "Total fair value of liabilities", "label": "Liabilities, Fair Value Disclosure" } } }, "auth_ref": [] }, "acet_LiabilitiesFairValueExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LiabilitiesFairValueExercised", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise", "label": "Liabilities Fair Value Exercised", "documentation": "Liabilities, fair value, exercised." } } }, "auth_ref": [] }, "acet_LiabilitiesFairValueSettled": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LiabilitiesFairValueSettled", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Termination", "label": "Liabilities Fair Value Settled", "documentation": "Liabilities, fair value, settled." } } }, "auth_ref": [] }, "acet_LicenceAgreementAdditionalAmountPayableOfOptionExerciseFees": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LicenceAgreementAdditionalAmountPayableOfOptionExerciseFees", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Licence agreement additional amount payable of option exercise fees", "label": "Licence Agreement Additional Amount Payable Of Option Exercise Fees", "documentation": "Additional amount payable of option exercise fees." } } }, "auth_ref": [] }, "acet_LicenceAgreementAdditionalRevenueRecognised": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LicenceAgreementAdditionalRevenueRecognised", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Licence agreement additional revenue recognised", "label": "Licence Agreement Additional Revenue Recognised", "documentation": "Licence agreement additional revenue recognised." } } }, "auth_ref": [] }, "acet_LicenceAgreementCumulativeRevenueRecognised": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LicenceAgreementCumulativeRevenueRecognised", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Licence agreement cumulative revenue recognised", "label": "Licence Agreement Cumulative Revenue Recognised", "documentation": "Cumulative revenue recognised." } } }, "auth_ref": [] }, "acet_LicenceAgreementUpfrontPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LicenceAgreementUpfrontPayment", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Upfront payment.", "terseLabel": "Upfront payment", "label": "Licence Agreement Upfront Payment" } } }, "auth_ref": [] }, "acet_LicenseAgreementAdditionalPaymentForResearchFundingReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LicenseAgreementAdditionalPaymentForResearchFundingReceived", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional payment for research funding received", "label": "License Agreement Additional Payment For Research Funding Received", "documentation": "Additional payment for research funding received." } } }, "auth_ref": [] }, "acet_LicenseAgreementCumulativeRevenueReductionRecognised": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LicenseAgreementCumulativeRevenueReductionRecognised", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "License agreement cumulative revenue reduction recognised.", "terseLabel": "License agreement cumulative revenue reduction recognised", "label": "License Agreement Cumulative Revenue Reduction Recognised" } } }, "auth_ref": [] }, "acet_LicenseAgreementMilestonePaymentsUponSatisfactionOfClinicalMilestonesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LicenseAgreementMilestonePaymentsUponSatisfactionOfClinicalMilestonesPayable", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount payable upon satisfaction of clinical milestones", "label": "License Agreement Milestone Payments Upon Satisfaction Of Clinical Milestones Payable", "documentation": "License agreement milestone payments upon satisfaction of clinical milestones payable." } } }, "auth_ref": [] }, "acet_LicenseAgreementMilestonePaymentsUponSatisfactionOfCommercialMilestonesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LicenseAgreementMilestonePaymentsUponSatisfactionOfCommercialMilestonesPayable", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount payable upon satisfaction of commercial milestones", "label": "License Agreement Milestone Payments Upon Satisfaction Of Commercial Milestones Payable", "documentation": "License agreement milestone payments upon satisfaction of commercial milestones payable." } } }, "auth_ref": [] }, "acet_LicenseAgreementMilestonePaymentsUponSatisfactionOfRegulatoryMilestonesPayableForFirstIndicationApproved": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LicenseAgreementMilestonePaymentsUponSatisfactionOfRegulatoryMilestonesPayableForFirstIndicationApproved", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount payable upon satisfaction of regulatory milestones for first indication approved", "label": "License Agreement Milestone Payments Upon Satisfaction Of Regulatory Milestones Payable For First Indication Approved", "documentation": "License agreement milestone payments upon satisfaction of regulatory milestones payable for first indication approved." } } }, "auth_ref": [] }, "acet_LicenseAgreementMilestonePaymentsUponSatisfactionOfRegulatoryMilestonesPayableForSecondIndicationApproved": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LicenseAgreementMilestonePaymentsUponSatisfactionOfRegulatoryMilestonesPayableForSecondIndicationApproved", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount payable upon satisfaction of regulatory milestones for second indication approved", "label": "License Agreement Milestone Payments Upon Satisfaction Of Regulatory Milestones Payable For Second Indication Approved", "documentation": "License agreement milestone payments upon satisfaction of regulatory milestones payable for second indication approved." } } }, "auth_ref": [] }, "acet_LicenseAgreementTerminationDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LicenseAgreementTerminationDescription", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "License agreement termination description", "label": "License Agreement Termination Description", "documentation": "License agreement termination description." } } }, "auth_ref": [] }, "acet_LicenseAndCollaborationRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LicenseAndCollaborationRevenue", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "License and collaboration revenue", "label": "License and collaboration revenue", "terseLabel": "License and collaboration revenue" } } }, "auth_ref": [] }, "acet_LicenseFundingAndOtherAgreementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LicenseFundingAndOtherAgreementsAbstract", "lang": { "en-us": { "role": { "label": "License Funding And Other Agreements [Abstract]", "documentation": "License funding and other agreements." } } }, "auth_ref": [] }, "acet_LicenseFundingAndOtherAgreementsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LicenseFundingAndOtherAgreementsTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreements1" ], "lang": { "en-us": { "role": { "terseLabel": "License, Funding and Other Agreements Related to the CVR", "label": "License Funding And Other Agreements [Text Block]", "documentation": "License funding and other agreements." } } }, "auth_ref": [] }, "acet_LoanAmountDrawn": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LoanAmountDrawn", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Loan Amount Drawn", "terseLabel": "Loan amount drawn", "documentation": "Loan amount drawn" } } }, "auth_ref": [] }, "us-gaap_LoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LoansPayable", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Loans Payable, Total", "label": "Loans Payable", "terseLabel": "Outstanding balance under the loan agreement" } } }, "auth_ref": [] }, "us-gaap_LoansReceivableBasisSpreadOnVariableRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LoansReceivableBasisSpreadOnVariableRate", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate for term loan to finance leasehold improvements", "label": "Loans Receivable, Basis Spread on Variable Rate" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermDebtDescription", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Description", "terseLabel": "Long-term Debt, Description" } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermPurchaseCommitmentLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfWeightedAverageIBRAndRemainingLeaseTermDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long Term Purchase Commitment [Line Items]", "label": "Long-Term Purchase Commitment [Line Items]" } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermPurchaseCommitmentTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfWeightedAverageIBRAndRemainingLeaseTermDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long Term Purchase Commitment [Table]", "label": "Long-Term Purchase Commitment [Table]" } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Axis]" } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Domain]" } } }, "auth_ref": [] }, "acet_LumpSumCompensationPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "LumpSumCompensationPayment", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lump sum payable", "label": "Lump Sum Compensation Payment", "documentation": "Lump sum compensation payment." } } }, "auth_ref": [] }, "acet_MLimitation": { "xbrltype": "percentItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "MLimitation", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "162m limitation", "label": "162m Limitation", "documentation": "162m Limitation" } } }, "auth_ref": [] }, "us-gaap_MarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MarketableSecurities", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesSummaryOfClassificationOfMarketableDebtSecuritiesInConsolidatedBalanceSheetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesSummaryOfClassificationOfMarketableDebtSecuritiesInConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Marketable debt securities", "label": "Marketable Securities", "terseLabel": "Marketable securities" } } }, "auth_ref": [] }, "us-gaap_MarketableSecuritiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MarketableSecuritiesLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities [Line Items]", "label": "Marketable Securities [Line Items]" } } }, "auth_ref": [] }, "acet_MarketableSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "MarketableSecuritiesMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities", "label": "Marketable Securities [Member]", "documentation": "Marketable securities." } } }, "auth_ref": [] }, "us-gaap_MarketableSecuritiesPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MarketableSecuritiesPolicy", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities", "label": "Marketable Securities, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_MarketableSecuritiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MarketableSecuritiesTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities [Table]", "label": "Marketable Securities [Table]" } } }, "auth_ref": [] }, "us-gaap_MarketableSecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MarketableSecuritiesTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Marketable Debt Securities", "label": "Marketable Securities [Table Text Block]" } } }, "auth_ref": [] }, "acet_MaximumAggregateValueOfCommonStockAvailableForOfferingAtMarketPriceUnderSalesAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "MaximumAggregateValueOfCommonStockAvailableForOfferingAtMarketPriceUnderSalesAgreement", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum aggregate value of common stock available for offering at-the-market price", "label": "Maximum Aggregate Value Of Common Stock Available For Offering At Market Price Under Sales Agreement", "documentation": "Maximum aggregate value of common stock available for offering at-the-market price under sales agreement." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "MaximumMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r62" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r62" ] }, "acet_MenloParkLeaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "MenloParkLeaseAgreementMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfWeightedAverageIBRAndRemainingLeaseTermDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Menlo Park, CA", "terseLabel": "Menlo Park Lease Agreement [Member]", "label": "Menlo Park Lease Agreement [Member]", "documentation": "Menlo Park lease agreement." } } }, "auth_ref": [] }, "acet_MergerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "MergerMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Merger", "label": "Merger [Member]", "documentation": "Merger." } } }, "auth_ref": [] }, "acet_MilestoneClosingLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "MilestoneClosingLiability", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Milestone closing liability", "label": "Milestone Closing Liability", "documentation": "Milestone closing liability." } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "MinimumMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum [Member]", "label": "Minimum [Member]" } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r82" ] }, "us-gaap_MoneyMarketFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MoneyMarketFundsMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Money Market Funds", "label": "Money Market Funds [Member]" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r90" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r63" ] }, "acet_NationalInstitutesOfHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "NationalInstitutesOfHealthMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "National Institute of Health", "label": "National Institutes Of Health [Member]", "documentation": "National Institutes of Health." } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 0.0 }, "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "totalLabel": "Net loss", "verboseLabel": "Segment net loss", "negatedTotalLabel": "Segment net loss" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Income (Loss) Available to Common Stockholders, Basic, Total", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Net Income (Loss) Available to Common Stockholders, Basic" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Net Income (Loss) Available to Common Stockholders, Diluted, Total", "terseLabel": "Net Income (Loss) Available to Common Stockholders, Diluted" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r62" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r25", "r36", "r46", "r70", "r79" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r53" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r52" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r70" ] }, "acet_NonProgramSpecificExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "NonProgramSpecificExpenses", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails": { "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Non Program Specific Expenses", "documentation": "Non Program Specific Expenses", "terseLabel": "Non-program specific expenses" } } }, "auth_ref": [] }, "acet_NonRefundableUpfrontPaymentReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "NonRefundableUpfrontPaymentReceived", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non refundable upfront payment received", "label": "Non Refundable Upfront Payment Received", "documentation": "Non refundable upfront payment received." } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r90" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r90" ] }, "us-gaap_NoninterestExpenseOfferingCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NoninterestExpenseOfferingCost", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Offering Cost, Expense", "terseLabel": "Estimated offering expenses" } } }, "auth_ref": [] }, "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Restricted Stock Activity", "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]" } } }, "auth_ref": [] }, "acet_NovartisInternationalPharmaceuticalLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "NovartisInternationalPharmaceuticalLimitedMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Novartis International Pharmaceutical Ltd.", "label": "Novartis International Pharmaceutical Limited [Member]", "documentation": "Novartis International Pharmaceutical Ltd. (\u201cNovartis\u201d)." } } }, "auth_ref": [] }, "acet_NovartisLicenseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "NovartisLicenseAgreementMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Novartis License Agreement", "label": "Novartis License Agreement [Member]", "documentation": "Novartis license agreement." } } }, "auth_ref": [] }, "acet_NumberOfCustomer": { "xbrltype": "integerItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "NumberOfCustomer", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of customer", "label": "Number Of Customer", "documentation": "Number of customer." } } }, "auth_ref": [] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number of Reportable Segments" } } }, "auth_ref": [] }, "acet_NumberOfSecuritiesConvertedToWarrantsToPurchaseCommonStock": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "NumberOfSecuritiesConvertedToWarrantsToPurchaseCommonStock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of warrants, Impact of converting to warrants for the purchase of common stock and adjusted for the Exchange Ratio and Reverse Stock Split", "label": "Number Of Securities Converted To Warrants To Purchase Common Stock", "documentation": "Number Of Securities Converted To Warrants To Purchase Common Stock." } } }, "auth_ref": [] }, "acet_NumberOfSharesAvailableForSaleUnderEmployeeStockPurchasePlan": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "NumberOfSharesAvailableForSaleUnderEmployeeStockPurchasePlan", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares available for sale under employee stock purchase plan", "label": "Number Of Shares Available For Sale Under Employee Stock Purchase Plan", "documentation": "Number of shares available for sale under employee stock purchase plan." } } }, "auth_ref": [] }, "acet_NumberOfSharesOfSurvivingStockOptions": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "NumberOfSharesOfSurvivingStockOptions", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of surviving stock options", "label": "Number Of Shares Of Surviving Stock Options", "documentation": "Number of shares of surviving stock options." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses" } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses:", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Operating Income (Loss)" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease cost", "label": "Operating Lease, Cost" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueRollingMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLiabilitiesPaymentsDueRollingMaturityAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails2": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails3": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liability", "label": "Operating Lease, Liability", "totalLabel": "Total lease liability" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 0.0 }, "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails3": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Less: current portion", "terseLabel": "Operating lease liability", "label": "Operating Lease, Liability, Current", "negatedLabel": "Less: current portion" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 }, "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails3": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liability, net of current portion", "label": "Operating Lease, Liability, Noncurrent", "totalLabel": "Operating Lease, Liability, Noncurrent, Total", "verboseLabel": "Lease liability, net of current maturities" } } }, "auth_ref": [] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating cash flows used for lease payments", "terseLabel": "Lease payments", "label": "Operating Lease, Payments" } } }, "auth_ref": [] }, "acet_OperatingLeaseProceedsPaymentsUse": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "OperatingLeaseProceedsPaymentsUse", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Operating Lease, Proceeds Payments, Use", "label": "Operating Lease, Proceeds Payments, Use", "terseLabel": "Operating cash flows used for lease liabilities" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease right-of-use asset", "terseLabel": "Operating lease right-of-use asset", "label": "Operating Lease, Right-of-Use Asset" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfWeightedAverageIBRAndRemainingLeaseTermDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted-average discount rate - operating leases" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfWeightedAverageIBRAndRemainingLeaseTermDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining Terms (in years)", "label": "Operating Lease, Weighted Average Remaining Lease Term", "verboseLabel": "Weighted-average remaining lease term - operating leases (in years)" } } }, "auth_ref": [] }, "acet_OperatingLeasesFutureMinimumSubleaseIncomeDue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "OperatingLeasesFutureMinimumSubleaseIncomeDue", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSubleaseIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSubleaseIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Leases Future Minimum Sublease Income Due", "documentation": "Operating Leases Future Minimum Sublease Income Due", "terseLabel": "Total", "totalLabel": "Total" } } }, "auth_ref": [] }, "acet_OperatingLeasesFutureMinimumSubleaseIncomeDueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "OperatingLeasesFutureMinimumSubleaseIncomeDueCurrent", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSubleaseIncomeDetails": { "parentTag": "acet_OperatingLeasesFutureMinimumSubleaseIncomeDue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSubleaseIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Leases Future Minimum Sublease Income Due Current", "documentation": "Operating Leases Future Minimum Sublease Income Due Current", "terseLabel": "2026" } } }, "auth_ref": [] }, "acet_OperatingLeasesFutureMinimumSubleaseIncomeDueInThreeYears": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "OperatingLeasesFutureMinimumSubleaseIncomeDueInThreeYears", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSubleaseIncomeDetails": { "parentTag": "acet_OperatingLeasesFutureMinimumSubleaseIncomeDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSubleaseIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Leases Future Minimum Sublease Income Due In Three Years", "documentation": "Operating Leases Future Minimum Sublease Income Due In Three Years", "terseLabel": "2027 and thereafter" } } }, "auth_ref": [] }, "acet_OperatingLeasesFutureMinimumSubleaseIncomeDueInTwoYears": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "OperatingLeasesFutureMinimumSubleaseIncomeDueInTwoYears", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSubleaseIncomeDetails": { "parentTag": "acet_OperatingLeasesFutureMinimumSubleaseIncomeDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfSubleaseIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Leases Future Minimum Sublease Income Due In Two Years", "documentation": "Operating Leases Future Minimum Sublease Income Due In Two Years", "terseLabel": "2027 and thereafter" } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Operating Loss Carryforwards, Total", "terseLabel": "Operating loss carryforwards", "label": "Operating Loss Carryforwards" } } }, "auth_ref": [] }, "acet_OperatingLossCarryforwardsIndefinitely": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "OperatingLossCarryforwardsIndefinitely", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards Indefinitely", "documentation": "Operating loss carryforwards indefinitely.", "terseLabel": "Operating loss carryforwards indefinitely" } } }, "auth_ref": [] }, "acet_OptionToPurchaseOfCommonStockAtPublicOfferingPrice": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "OptionToPurchaseOfCommonStockAtPublicOfferingPrice", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Option to purchase of common stock at public offering price", "label": "Option To Purchase Of Common Stock At Public Offering Price", "documentation": "Option to purchase of common stock at public offering price." } } }, "auth_ref": [] }, "acet_OptionsAvailableForFutureGrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "OptionsAvailableForFutureGrantsMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceDetails" ], "lang": { "en-us": { "role": { "label": "Options Available For Future Grants [Member]", "documentation": "Options available for future grants.", "terseLabel": "Stock Options Available for Future Grant" } } }, "auth_ref": [] }, "acet_OrganizationAndNatureOfBusinessAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "OrganizationAndNatureOfBusinessAbstract", "lang": { "en-us": { "role": { "label": "Organization And Nature Of Business [Abstract]", "documentation": "Organization and Nature of Business." } } }, "auth_ref": [] }, "acet_OrganizationAndNatureOfBusinessTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "OrganizationAndNatureOfBusinessTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusiness" ], "lang": { "en-us": { "role": { "terseLabel": "Organization and Nature of Business", "label": "Organization And Nature Of Business [Text Block]", "documentation": "Organization and nature of business." } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesSummaryOfAccruedAndOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesSummaryOfAccruedAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued other liabilities", "label": "Other Accrued Liabilities, Current" } } }, "auth_ref": [] }, "us-gaap_OtherAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAssetImpairmentCharges", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Asset Impairment Charges", "terseLabel": "Impairment Charges" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other prepaid expenses and current assets", "label": "Other Assets, Current" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Other Assets, Noncurrent, Total", "terseLabel": "Other non-current assets", "label": "Other Assets, Noncurrent" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossBeforeTax", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), before Tax", "totalLabel": "Total other comprehensive income" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "totalLabel": "Other Comprehensive Income (Loss), Net of Tax, Total", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive loss", "verboseLabel": "Other comprehensive income" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive income" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gain (loss) on marketable debt securities, net of tax", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities", "label": "Other Liabilities, Noncurrent" } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Other Nonoperating Income (Expense), Total", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other expense, net" } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherNonoperatingIncomeExpenseMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Income (Expense) [Member]", "label": "Other Nonoperating Income (Expense) [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Operating Income (Expense), Net", "totalLabel": "Other income, net", "terseLabel": "Other expense, net" } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r62" ] }, "acet_OtherProgramsExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "OtherProgramsExpenses", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails": { "parentTag": "acet_TotalExternalProgramExpensesForProductCandidates", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Programs Expenses", "documentation": "Other Programs Expenses", "terseLabel": "Other programs" } } }, "auth_ref": [] }, "acet_OtherProgramsExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "OtherProgramsExpensesMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other programs", "label": "Other Programs Expenses [Member]", "documentation": "Other Programs Expenses [Member]" } } }, "auth_ref": [] }, "acet_OtherSegmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "OtherSegmentExpense", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails": { "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Other Segment Expense", "documentation": "Other Segment Expense", "terseLabel": "Other segment expense" } } }, "auth_ref": [] }, "us-gaap_OtherShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherShortTermInvestments", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Short-Term Investments", "terseLabel": "Short-term investments in treasury securities" } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r23", "r34", "r44", "r77" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r26", "r37", "r47", "r80" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r26", "r37", "r47", "r80" ] }, "acet_OwnershipChangePlanDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "OwnershipChangePlanDescription", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership change plan description", "label": "Ownership Change Plan Description", "documentation": "Ownership change plan description." } } }, "auth_ref": [] }, "acet_PacificWesternBankMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "PacificWesternBankMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Pacific western bank [Member]", "documentation": "Pacific western bank [Member]", "terseLabel": "Pacific western bank" } } }, "auth_ref": [] }, "acet_PacwestMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "PacwestMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "PacWest", "label": "PacWest [Member]", "documentation": "PacWest [Member]" } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r51" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsForMergerRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsForMergerRelatedCosts", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction cost for merger", "label": "Payments for Merger Related Costs" } } }, "auth_ref": [] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Payments for Repurchase of Common Stock", "terseLabel": "Payments for repurchase of common stock" } } }, "auth_ref": [] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares withheld for taxes, Value", "terseLabel": "Shares withheld for taxes, Value", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement" } } }, "auth_ref": [] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r61" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r61" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r53" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r70" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r63" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r52" ] }, "acet_PercentageOfCashFullyInsured": { "xbrltype": "percentItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "PercentageOfCashFullyInsured", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of cash fully insured", "label": "Percentage Of Cash Fully Insured", "documentation": "Percentage Of Cash Fully Insured" } } }, "auth_ref": [] }, "acet_PerformanceRestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "PerformanceRestrictedStockMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Performance restricted stock.", "label": "Performance Restricted Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PerformanceSharesMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Performance Shares [Member]" } } }, "auth_ref": [] }, "acet_PersonnelRelatedExpensesIncludingStockBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "PersonnelRelatedExpensesIncludingStockBasedCompensation", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails": { "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Personnel Related Expenses Including Stock Based Compensation", "documentation": "Personnel Related Expenses Including Stock Based Compensation", "terseLabel": "Personnel-related expenses (including stock-based compensation)" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PlanNameAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name", "label": "Plan Name [Axis]" } } }, "auth_ref": [] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PlanNameDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name", "label": "Plan Name [Domain]" } } }, "auth_ref": [] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Adjustments Prior Service Cost [Member]", "terseLabel": "Pension Adjustments Prior Service Cost" } } }, "auth_ref": [ "r54" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Adjustments Service Cost [Member]", "terseLabel": "Pension Adjustments Service Cost" } } }, "auth_ref": [ "r110" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Benefits Adjustments, Footnote [Text Block]", "terseLabel": "Pension Benefits Adjustments, Footnote" } } }, "auth_ref": [ "r53" ] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureBusinessCombinationScheduleOfChangesInTheCompanysIprdAndCvrSinceTheMergerDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "axisDefault": "Portion at Fair Value Measurement [Member] [Default]", "terseLabel": "Fair Value Disclosure Item Amounts [Default]", "label": "Portion at Fair Value Measurement [Member]" } } }, "auth_ref": [] }, "acet_PostExposureProphylaxisDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "PostExposureProphylaxisDescription", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Post Exposure Prophylaxis in adults", "label": "Post Exposure Prophylaxis Description", "documentation": "Post Exposure Prophylaxis in adults" } } }, "auth_ref": [] }, "acet_PreFundedWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "PreFundedWarrantMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Pre Funded Warrant [Member]", "label": "Pre Funded Warrant [Member]", "terseLabel": "Pre Funded Warrant [Member]" } } }, "auth_ref": [] }, "us-gaap_PreferredStockLiquidationPreferenceValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockLiquidationPreferenceValue", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, liquidation preference, value", "label": "Preferred Stock, Liquidation Preference, Value" } } }, "auth_ref": [] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock, par value", "label": "Preferred Stock, Par or Stated Value Per Share" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock shares authorized", "label": "Preferred Stock, Shares Authorized" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "totalLabel": "Preferred Stock, Shares Issued, Total", "terseLabel": "Preferred stock shares issued", "label": "Preferred Stock, Shares Issued" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance", "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance", "terseLabel": "Preferred stock shares outstanding", "label": "Preferred Stock, Shares Outstanding" } } }, "auth_ref": [] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance", "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance", "totalLabel": "Preferred Stock, Value, Issued, Total", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.0001 par value, 10,000,000 shares authorized as of December 31, 2025 and December 31, 2024, respectively; none issued and outstanding as of December 30, 2025 and December 31, 2024, respectively" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total prepaid expenses and other current assets", "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract", "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Prepaid Expense, Current, Total", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid maintenance" } } }, "auth_ref": [] }, "acet_PrepaidExpensesAndOtherCurrentAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "PrepaidExpensesAndOtherCurrentAssetsTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Prepaid Expenses and Other Current Assets", "label": "Prepaid Expenses And Other Current Assets Table [Text Block]", "documentation": "Tabular disclosure of the summary of Prepaid expenses and other current assets." } } }, "auth_ref": [] }, "acet_PrepaidExpensesAndOtherCurrentAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "PrepaidExpensesAndOtherCurrentAssetsTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid Expenses and Other Current Assets", "label": "Prepaid Expenses And Other Current Assets [Text Block]", "documentation": "Prepaid expenses and other current assets." } } }, "auth_ref": [] }, "us-gaap_PrepaidInsurance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PrepaidInsurance", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid insurance", "label": "Prepaid Insurance" } } }, "auth_ref": [] }, "acet_PrepaidSoftwareSubscriptionAndLicensingFees": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "PrepaidSoftwareSubscriptionAndLicensingFees", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid software subscription and licensing fees", "label": "Prepaid software subscription and licensing fees", "documentation": "Prepaid software subscription and licensing fees" } } }, "auth_ref": [] }, "acet_PrepaymentsToCrosAndCdmos": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "PrepaymentsToCrosAndCdmos", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepayments to CROs and CDMOs", "label": "Prepayments to CROs and CDMOs", "documentation": "Prepayments to CROs and CDMOs" } } }, "auth_ref": [] }, "us-gaap_PrimeRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PrimeRateMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prime Rate", "label": "Prime Rate [Member]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromIssuanceInitialPublicOffering", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of common stock pursuant to at-the-market offering, net of issuance costs", "label": "Proceeds from Issuance Initial Public Offering", "verboseLabel": "Aggregate net proceeds" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of common stock pursuant to at-the-market offering, net of issuance costs" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Proceeds from Issuance or Sale of Equity", "label": "Proceeds from Issuance or Sale of Equity" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromRelatedPartyDebt", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Related Party Debt", "terseLabel": "Revenue from related party" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from exercise of stock options", "label": "Proceeds from Stock Options Exercised", "verboseLabel": "Payment from Regeneron for exercise of its option to license exclusive rights" } } }, "auth_ref": [] }, "us-gaap_ProfessionalAndContractServicesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProfessionalAndContractServicesExpense", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails": { "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Professional and Contract Services Expense", "terseLabel": "Professional services and consulting fees" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset", "label": "Long-Lived Tangible Asset [Axis]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNet1" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment, Net", "label": "Property, Plant and Equipment Disclosure [Text Block]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance", "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance", "totalLabel": "Property, Plant and Equipment, Gross, Total", "terseLabel": "Total property and equipment", "label": "Property, Plant and Equipment, Gross" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property Plant And Equipment [Line Items]", "label": "Property, Plant and Equipment [Line Items]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 }, "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance", "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance", "totalLabel": "Property and equipment, net", "terseLabel": "Property and equipment, net", "label": "Property, Plant and Equipment, Net" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment, Net", "label": "Property, Plant and Equipment, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Property and Equipment, Net", "label": "Property, Plant and Equipment [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset", "label": "Long-Lived Tangible Asset [Domain]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Useful life (in years)", "label": "Property, Plant and Equipment, Useful Life" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]", "terseLabel": "Lesser of useful life or lease term" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r51" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r51" ] }, "acet_QualifyingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "QualifyingExpenses", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Qualifying expenses", "label": "Qualifying Expenses", "documentation": "Qualifying expenses." } } }, "auth_ref": [] }, "acet_QualifyingExpensesOnCumulativeBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "QualifyingExpensesOnCumulativeBasis", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Qualifying expenses on cumulative basis", "label": "Qualifying Expenses On Cumulative Basis", "documentation": "qualifying expenses on cumulative basis." } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RangeAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RangeMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [] }, "acet_RecognitionOfContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "RecognitionOfContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recognition of contingent consideration liability", "label": "Recognition Of Contingent Consideration Liability", "documentation": "Recognition of contingent consideration liability." } } }, "auth_ref": [] }, "acet_RecognitionOfPreferredStockWarrantLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "RecognitionOfPreferredStockWarrantLiabilities", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recognition of preferred stock warrant liabilities", "label": "Recognition Of Preferred Stock Warrant Liabilities", "documentation": "Recognition of preferred stock warrant liabilities." } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r18", "r29", "r39", "r72" ] }, "us-gaap_RedeemableConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RedeemableConvertiblePreferredStockMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable Convertible Preferred Stock", "label": "Redeemable Convertible Preferred Stock [Member]" } } }, "auth_ref": [] }, "acet_RedeemableConvertiblePreferredStockPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "RedeemableConvertiblePreferredStockPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable Convertible Preferred Stock", "label": "Redeemable Convertible Preferred Stock Policy [Text Block]", "documentation": "Disclosure of accounting policy for redeemable convertible preferred stock." } } }, "auth_ref": [] }, "acet_RedeemableConvertiblePreferredStockTrancheLiabilityAndTRDFObligationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "RedeemableConvertiblePreferredStockTrancheLiabilityAndTRDFObligationMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable Convertible Preferred Stock Tranche Liability And TRDF Obligation", "label": "Redeemable Convertible Preferred Stock Tranche Liability And T R D F Obligation [Member]", "documentation": "Redeemable convertible preferred stock tranche liability and TRDF obligation." } } }, "auth_ref": [] }, "acet_RedeemableConvertiblePreferredStockTrancheLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "RedeemableConvertiblePreferredStockTrancheLiabilityMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable Convertible Preferred Stock Tranche Liability", "label": "Redeemable Convertible Preferred Stock Tranche Liability [Member]", "documentation": "Redeemable convertible preferred stock tranche liability." } } }, "auth_ref": [] }, "acet_RedeemableConvertiblePreferredStockTrancheLiabilityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "RedeemableConvertiblePreferredStockTrancheLiabilityPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable Convertible Preferred Stock Tranche Liability", "label": "Redeemable Convertible Preferred Stock Tranche Liability Policy [Text Block]", "documentation": "Redeemable convertible preferred stock tranche liability." } } }, "auth_ref": [] }, "acet_RedeemableConvertiblePreferredStockWarrantLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "RedeemableConvertiblePreferredStockWarrantLiabilityMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable Convertible Preferred Stock Warrant Liability", "label": "Redeemable Convertible Preferred Stock Warrant Liability [Member]", "documentation": "Redeemable convertible preferred stock warrant liability." } } }, "auth_ref": [] }, "acet_RedeemableConvertiblePreferredStockWarrantLiabilityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "RedeemableConvertiblePreferredStockWarrantLiabilityPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable Convertible Preferred Stock Warrants", "label": "Redeemable Convertible Preferred Stock Warrant Liability Policy [Text Block]", "documentation": "Redeemable convertible preferred stock warrants." } } }, "auth_ref": [] }, "acet_RedeemableConvertiblePreferredStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "RedeemableConvertiblePreferredStockWarrantsMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Redeemable Convertible Preferred Stock Warrants", "terseLabel": "Redeemable Convertible Preferred Stock Warrant Liability", "label": "Redeemable Convertible Preferred Stock Warrants [Member]", "documentation": "Redeemable convertible preferred stock warrants member" } } }, "auth_ref": [] }, "acet_RedwoodCityLeaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "RedwoodCityLeaseAgreementMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureRestrictedCashRestrictedCashOnTheCompanysConsolidatedBalanceSheetsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfWeightedAverageIBRAndRemainingLeaseTermDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Redwood City, CA (1000 Bridge Parkway)", "label": "Redwood City Lease Agreement [Member]", "documentation": "Redwood City lease agreement.", "terseLabel": "Redwood City, CA lease [Member]" } } }, "auth_ref": [] }, "acet_RedwoodCityLeaseAgreementOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "RedwoodCityLeaseAgreementOneMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesScheduleOfWeightedAverageIBRAndRemainingLeaseTermDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redwood City, CA (1200 Bridge Parkway)", "label": "Redwood City Lease Agreement One [Member]", "documentation": "Redwood City Lease Agreement One [Member]" } } }, "auth_ref": [] }, "acet_RegeneronPharmaceuticalsIncorporationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "RegeneronPharmaceuticalsIncorporationMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Regeneron Pharmaceuticals Incorporation.", "terseLabel": "Regeneron Pharmaceuticals, Inc.", "label": "Regeneron Pharmaceuticals Incorporation [Member]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "label": "Related and Nonrelated Parties [Domain]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction", "label": "Related Party Transaction [Axis]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction", "label": "Related Party Transaction [Domain]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Line Items]", "label": "Related Party Transaction [Line Items]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "label": "Related and Nonrelated Parties [Axis]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactions" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transactions", "label": "Related Party Transactions Disclosure [Text Block]" } } }, "auth_ref": [] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "auth_ref": [] }, "acet_ResTORbioMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ResTORbioMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyParentheticalDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "resTORbio", "label": "Res T O Rbio [Member]", "documentation": "resTORbio." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type", "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research And Development Arrangement Contract To Perform For Others [Line Items]", "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type", "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "totalLabel": "Research and Development Expense, Total", "label": "Research and Development Expense" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research And Development Expenses", "label": "Research and Development Expense [Member]" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development Expenses", "label": "Research and Development Expense, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "acet_ResearchAndDevelopmentInProcess1": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ResearchAndDevelopmentInProcess1", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development in process 1", "documentation": "Research and development in process 1", "label": "Research and development in process 1" } } }, "auth_ref": [] }, "acet_ResearchFundingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ResearchFundingAgreementMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research Funding Agreement", "label": "Research Funding Agreement [Member]", "documentation": "Research funding agreement." } } }, "auth_ref": [] }, "acet_ResearchFundingFee": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ResearchFundingFee", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Research funding fee", "label": "Research funding fee" } } }, "auth_ref": [] }, "srt_RestatementAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RestatementAdjustmentMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Period Adjustments", "label": "Revision of Prior Period, Adjustment [Member]" } } }, "auth_ref": [] }, "srt_RestatementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RestatementAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revision of Prior Period", "label": "Revision of Prior Period [Axis]" } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r19", "r30", "r40", "r73" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r20", "r31", "r41", "r74" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r27", "r38", "r48", "r81" ] }, "srt_RestatementDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RestatementDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revision of Prior Period", "label": "Revision of Prior Period [Domain]" } } }, "auth_ref": [] }, "us-gaap_RestrictedAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedAssetsDisclosureTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureRestrictedCash1" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Cash", "label": "Restricted Assets Disclosure [Text Block]" } } }, "auth_ref": [] }, "us-gaap_RestrictedCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedCash", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureRestrictedCashAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Cash", "totalLabel": "Restricted Cash, Total", "terseLabel": "Restricted Cash" } } }, "auth_ref": [] }, "us-gaap_RestrictedCashAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedCashAbstract", "lang": { "en-us": { "role": { "label": "Restricted Cash [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureRestrictedCashRestrictedCashOnTheCompanysConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Cash and Cash Equivalents [Axis]" } } }, "auth_ref": [] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureRestrictedCashRestrictedCashOnTheCompanysConsolidatedBalanceSheetsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents [Domain]" } } }, "auth_ref": [] }, "us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedCashAndCashEquivalentsItemsLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureRestrictedCashRestrictedCashOnTheCompanysConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Cash and Cash Equivalent Item [Line Items]" } } }, "auth_ref": [] }, "us-gaap_RestrictedCashNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedCashNoncurrent", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureRestrictedCashRestrictedCashOnTheCompanysConsolidatedBalanceSheetsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "periodEndLabel": "Restricted cash", "label": "Restricted Cash, Noncurrent" } } }, "auth_ref": [] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedStockMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock", "label": "Restricted Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unvested restricted stock units", "label": "Restricted Stock Units (RSUs) [Member]", "verboseLabel": "Restricted Stock Units (RSUs)" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance", "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance", "totalLabel": "Retained Earnings (Accumulated Deficit), Total", "negatedLabel": "Accumulated deficit", "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RetainedEarningsMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings [Member]" } } }, "auth_ref": [] }, "us-gaap_RevenueRecognitionAndDeferredRevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RevenueRecognitionAndDeferredRevenueAbstract", "lang": { "en-us": { "role": { "label": "Revenue Recognition and Deferred Revenue [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Revenue [Policy Text Block]" } } }, "auth_ref": [] }, "acet_RisksAndUncertaintiesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "RisksAndUncertaintiesPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Risks and Uncertainties", "label": "Risks And Uncertainties Policy [Text Block]", "documentation": "Risks and uncertainties policy text block." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r90" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r90" ] }, "acet_SaleOfShare": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "SaleOfShare", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Sale Of Share", "label": "Sale Of Share", "terseLabel": "Share sale" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SaleOfStockConsiderationReceivedOnTransaction", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock, Consideration Received on Transaction", "terseLabel": "Net proceeds from the offering, after deducting expenses" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SaleOfStockConsiderationReceivedPerTransaction", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from the offering", "label": "Sale of Stock, Consideration Received Per Transaction" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockDescriptionOfTransaction": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SaleOfStockDescriptionOfTransaction", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock, Description of Transaction", "terseLabel": "Description of stock purchase agreement" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of Stock", "label": "Sale of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Aggregate number of shares sold", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Number of common stock shares sold" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SaleOfStockPricePerShare", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Sale of Stock, Price Per Share", "label": "Sale of Stock, Price Per Share", "terseLabel": "Public offering price" } } }, "auth_ref": [] }, "acet_SalesAgentCommissionsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "SalesAgentCommissionsAndExpenses", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales agent commissions and expenses", "label": "Sales agent commissions and expenses", "documentation": "Sales agent commissions and expenses" } } }, "auth_ref": [] }, "acet_SalesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "SalesAgreementMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales Agreement [Member]", "label": "Sales Agreement [Member]", "documentation": "Sales agreement member." } } }, "auth_ref": [] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ScenarioForecastMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forecast", "label": "Forecast [Member]" } } }, "auth_ref": [] }, "srt_ScenarioPreviouslyReportedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ScenarioPreviouslyReportedMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preliminary", "label": "Previously Reported [Member]" } } }, "auth_ref": [] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario", "label": "Scenario [Domain]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAccruedAndOtherCurrentLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Accrued and Other Current Liabilities", "label": "Schedule of Accrued Liabilities [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]", "label": "Antidilutive Security, Excluded EPS Calculation [Table]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Estimated Share Consideration of Combined Company", "label": "Business Combination, Contingent Consideration [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyParentheticalDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]", "label": "Business Combination [Table]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Summarizes the Allocation of the Purchase Price to the Net Tangible and Intangible Assets Acquired", "label": "Business Combination [Table Text Block]" } } }, "auth_ref": [] }, "acet_ScheduleOfChangesInFairValueOfUnobservableFinancialInstrumentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ScheduleOfChangesInFairValueOfUnobservableFinancialInstrumentsTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Changes in Fair Value of Level 3 Financial Instruments", "label": "Schedule Of Changes In Fair Value Of Unobservable Financial Instruments Table [Text Block]", "documentation": "Tabular disclosure of changes in the fair value of the unobservable financial instruments." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureThirdPartyAgreementsSummaryOfChangeInCompanysContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Stock-Based Compensation Expense", "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Components of Provision for (Benefit from) Income Taxes", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Deferred Tax Assets and Liabilities", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of (Provision for) Benefit from Income Taxes Differs from Federal Statutory Rate to the Loss Before Taxes", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "verboseLabel": "Schedule of Reconciliation of the Company's effective tax" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Equity Method Investments [Line Items]", "label": "Schedule of Equity Method Investments [Line Items]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfEquityMethodInvestmentsTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Equity Method Investments [Table]", "label": "Equity Method Investment [Table]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Financial Assets and Liabilities Measured on Recurring Basis", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]" } } }, "auth_ref": [] }, "acet_ScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Number of Shares of Common Stock Reserved for Future Issuance", "label": "Schedule Of Number Of Shares Of Common Stock Reserved For Future Issuance [Text Block]", "documentation": "Schedule of number of shares of common stock reserved for future issuance." } } }, "auth_ref": [] }, "acet_ScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Outstanding Warrants to Purchase Shares of Common Stock", "label": "Schedule Of Outstanding Warrants To Purchase Shares Of Common Stock Table [Text Block]", "documentation": "Schedule of outstanding warrants to purchase shares of common stock ." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Property Plant And Equipment [Table]", "label": "Property, Plant and Equipment [Table]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]", "label": "Related Party Transaction [Table]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Research And Development Arrangement Contract To Perform For Others [Table]", "label": "Research and Development, Contract to Perform for Others [Table]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureRestrictedCashRestrictedCashOnTheCompanysConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "label": "Restrictions on Cash and Cash Equivalents [Table]" } } }, "auth_ref": [] }, "acet_ScheduleOfRestrictedCashOnTheCompanysConsolidatedBalanceSheets": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ScheduleOfRestrictedCashOnTheCompanysConsolidatedBalanceSheets", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureRestrictedCashTables" ], "lang": { "en-us": { "role": { "label": "Schedule of restricted cash on the Company's consolidated balance sheets", "documentation": "Schedule of restricted cash on the Company's consolidated balance sheets" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Company's segment information", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Summary of Restricted Stock Unit Activity" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Stock Option Activity", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assumptions to Estimate Fair Value of Stock Options Using Black-Scholes Option Pricing Model", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Stock By Class [Table]", "label": "Stock, Class of Stock [Table]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Outstanding Warrants", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]" } } }, "auth_ref": [] }, "acet_ScheduleOfSubleaseIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ScheduleOfSubleaseIncomeTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentsAndContingencesTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Sublease Income Table Text Block", "documentation": "Schedule Of Sublease Income.", "terseLabel": "Schedule Of Sublease Income" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reconciliation of Unrecognized Tax Benefits", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block]", "terseLabel": "Schedule of Vested Restricted Stock Units" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfVariableInterestEntitiesTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureShanghaiAdicetBiotechnologyCoLtdTheAdicetVieTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Variable Interest Entities [Table Text Block]", "terseLabel": "Summary of the carrying amount of assets and liabilities of VIE" } } }, "auth_ref": [] }, "acet_ScheduleOfWeightedAverageIBRAndRemainingLeaseTermTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ScheduleOfWeightedAverageIBRAndRemainingLeaseTermTableTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentsAndContingencesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Weighted Average IBR and Remaining Lease Term", "label": "Schedule Of Weighted Average I B R And Remaining Lease Term Table [Text Block]", "documentation": "Schedule of weighted average ibr and remaining lease term table text block." } } }, "auth_ref": [] }, "acet_Sec174CapitalizedRD": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "Sec174CapitalizedRD", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Sec 174 Capitalized R&D", "documentation": "Sec 174 Capitalized R&D", "terseLabel": "Sec 174 Capitalized R&D" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r3" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Segments [Domain]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReporting" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting", "label": "Segment Reporting Disclosure [Text Block]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Information [Line Items]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Segments", "label": "Segment Reporting, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "acet_SeptemberFifteenTwoThousandTwentyWarrantFourMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "SeptemberFifteenTwoThousandTwentyWarrantFourMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "lang": { "en-us": { "role": { "documentation": "September Fifteen Two Thousand Twenty Warrant Four.", "terseLabel": "September 15, 2020 Warrant Four", "label": "September Fifteen Two Thousand Twenty Warrant Four [Member]" } } }, "auth_ref": [] }, "acet_SeptemberFifteenTwoThousandTwentyWarrantOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "SeptemberFifteenTwoThousandTwentyWarrantOneMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "lang": { "en-us": { "role": { "documentation": "September Fifteen Two Thousand Twenty Warrant One.", "terseLabel": "September 15, 2020 Warrant One", "label": "September Fifteen Two Thousand Twenty Warrant One [Member]" } } }, "auth_ref": [] }, "acet_SeptemberFifteenTwoThousandTwentyWarrantThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "SeptemberFifteenTwoThousandTwentyWarrantThreeMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "lang": { "en-us": { "role": { "documentation": "September Fifteen Two Thousand Twenty Warrant Three.", "terseLabel": "September 15, 2020 Warrant Three", "label": "September Fifteen Two Thousand Twenty Warrant Three [Member]" } } }, "auth_ref": [] }, "acet_SeptemberFifteenTwoThousandTwentyWarrantTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "SeptemberFifteenTwoThousandTwentyWarrantTwoMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "lang": { "en-us": { "role": { "documentation": "September Fifteen Two Thousand Twenty Warrant Two.", "terseLabel": "September 15, 2020 Warrant Two", "label": "September Fifteen Two Thousand Twenty Warrant Two [Member]" } } }, "auth_ref": [] }, "us-gaap_SeriesBPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SeriesBPreferredStockMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series B Convertible Preferred Stock [ Member ]", "label": "Series B Preferred Stock [Member]" } } }, "auth_ref": [] }, "acet_SeriesBRedeemableConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "SeriesBRedeemableConvertiblePreferredStockMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" ], "lang": { "en-us": { "role": { "verboseLabel": "Series B Redeemable Convertible Preferred Stock", "terseLabel": "Series B Redeemable Convertible Preferred Stock", "label": "Series B Redeemable Convertible Preferred Stock [Member]", "documentation": "Series B redeemable convertible preferred stock." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetailsParenthetical" ], "lang": { "en-us": { "role": { "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total", "terseLabel": "Stock-based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "verboseLabel": "Non-cash stock-based compensation" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Noncash Expense [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date", "terseLabel": "Share purchase discount rate" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "RSUs granted" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-Average Grant Date Fair Value,Granted" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance", "periodEndLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "weighted-average grant date fair value", "periodStartLabel": "Weighted- Average Grant Date Fair Value, beginning balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility, maximum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility, minimum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum" } } }, "auth_ref": [] }, "acet_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValueOfCommonStock": { "xbrltype": "perShareItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValueOfCommonStock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair value of common stock", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value Of Common Stock", "documentation": "Share based compensation arrangement by share based payment award fair value assumptions fair value of common stock." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate, maximum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate, minimum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of additional shares reserved for issuance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares reserved for issuance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Shares Available for Grant, Beginning balance", "terseLabel": "Number of shares of common stock available for grant", "periodEndLabel": "Number of Shares Available for Grant, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant" } } }, "auth_ref": [] }, "acet_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantAsPartOfMerger": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantAsPartOfMerger", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Shares Available for Grant, Assumed as part of the Merger", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant As Part Of Merger", "documentation": "Share based compensation arrangement by share based payment award number of shares available for grant as part of merger." } } }, "auth_ref": [] }, "acet_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantSharesAuthorized", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Shares Available for Grant, Options authorized", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Shares Authorized", "documentation": "Share based compensation arrangement by share based payment award number of shares available for grant shares authorized." } } }, "auth_ref": [] }, "acet_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantSharesCancelled": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantSharesCancelled", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Shares Available for Grant, Options forfeited or cancelled", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Shares Cancelled", "documentation": "Share based compensation arrangement by share based payment award number of shares available for grant shares cancelled." } } }, "auth_ref": [] }, "acet_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantSharesExercised": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantSharesExercised", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Options exercised, Number of Shares Available for Grant", "terseLabel": "Number of Shares Available for Grant, Options exercised", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Shares Exercised", "documentation": "Share based compensation arrangement by share based payment award number of shares available for grant shares exercised." } } }, "auth_ref": [] }, "acet_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantSharesGranted": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantSharesGranted", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Shares Available for Grant, Options granted", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Shares Granted", "documentation": "Share based compensation arrangement by share based payment award number of shares available for grant, shares granted." } } }, "auth_ref": [] }, "acet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedAsPartOfMerger": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedAsPartOfMerger", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Shares Underlying Outstanding Options, Assumed as part of the Merger", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Assumed As Part Of Merger", "documentation": "Share based compensation arrangement by share based payment award options assumed as part of merger." } } }, "auth_ref": [] }, "acet_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAuthorized", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Shares Underlying Outstanding Options, Options authorized", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Authorized", "documentation": "Share based compensation arrangement by share based payment award options authorized." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Shares Underlying Outstanding Options, Shares exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Exercise Price, Shares exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate intrinsic value of options exercised", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Shares Underlying Outstanding Options, Options forfeited or cancelled", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "RSUs granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "verboseLabel": "Number of Shares Underlying Outstanding Options, Options granted" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value, Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Shares Underlying Outstanding Options, Beginning balance", "periodEndLabel": "Number of Shares Underlying Outstanding Options, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted-Average Exercise Price, Outstanding beginning", "periodEndLabel": "Weighted-Average Exercise Price, Outstanding ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value, Vested and expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Shares Underlying Outstanding Options, Vested and expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Exercise Price, Vested and expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost", "label": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types" } } }, "auth_ref": [] }, "acet_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedAsPartOfMergerInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedAsPartOfMergerInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Exercise Price, Assumed as part the Merger", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Assumed As Part Of Merger In Period Weighted Average Exercise Price", "documentation": "Share based compensation arrangements by share based payment award options assumed as part of merger in period weighted average exercise price." } } }, "auth_ref": [] }, "acet_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAuthorizedInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAuthorizedInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Exercise Price, Options, authorized", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Authorized In Period Weighted Average Exercise Price", "documentation": "Share based compensation arrangements by share based payment award options authorized in period weighted average exercise price." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted-Average Exercise Price, Options exercised", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price, Warrants exercised" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Exercise Price, Options forfeited or cancelled", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Warrants forfeited" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average exercise price", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted-Average Exercise Price, Warrants issued" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Tranche One", "label": "Share-Based Payment Arrangement, Tranche One [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationAwardTrancheThreeMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Tranche Three", "label": "Share-Based Payment Arrangement, Tranche Three [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationAwardTrancheTwoMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Tranche Two", "label": "Share-Based Payment Arrangement, Tranche Two [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-Based Compensation", "label": "Share-Based Payment Arrangement [Policy Text Block]" } } }, "auth_ref": [] }, "acet_ShareBasedPaymentArrangementIncrementalCostAmountRecognizedOverTheRemainingVestingPeriodOfRepricedOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "ShareBasedPaymentArrangementIncrementalCostAmountRecognizedOverTheRemainingVestingPeriodOfRepricedOptions", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Incremental Cost, Amount Recognized Over The Remaining Vesting Period Of Repriced Options", "documentation": "Share-Based Payment Arrangement, Incremental Cost, Amount Recognized Over The Remaining Vesting Period Of Repriced Options", "label": "Share-Based Payment Arrangement, Incremental Cost, Amount Recognized Over The Remaining Vesting Period Of Repriced Options" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration period closing of the merger", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsToEstimateFairValueOfStockOptionsUsingBlackScholesOptionPricingModelDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Expected term (in years)", "terseLabel": "Term", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value, Shares exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Remaining Contract Term, Shares exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "terseLabel": "RSUs forfeited", "negatedLabel": "RSUs forfeited" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, RSUs forfeited" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Beginning Balance", "periodEndLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "terseLabel": "Weighted- Average Grant Date Fair Value, beginning balance", "verboseLabel": "Weighted- Average Grant Date Fair Value, ending balance" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Remaining Contract Term, Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Remaining Contract Term, Vested and expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total fair value of options vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "RSUs Vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares", "terseLabel": "RSUs Vested" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Grant Date Fair Value,Vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value" } } }, "auth_ref": [] }, "acet_Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodexerciseprice": { "xbrltype": "perShareItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "Sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodexerciseprice", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantSharesGranted", "documentation": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePrice", "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Exercise Price" } } }, "auth_ref": [] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance price per shares", "label": "Shares Issued, Price Per Share", "verboseLabel": "Purchase price per share" } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharesOutstanding", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares, Outstanding", "periodEndLabel": "Ending Balance, shares", "periodStartLabel": "Beginning Balance, shares" } } }, "auth_ref": [] }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Shares withheld for taxes", "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation" } } }, "auth_ref": [] }, "us-gaap_ShortTermLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShortTermLeaseCost", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term lease cost", "label": "Short-Term Lease, Cost" } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Significant Accounting Policies", "label": "Significant Accounting Policies [Text Block]" } } }, "auth_ref": [] }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Software", "label": "Software and Software Development Costs [Member]" } } }, "auth_ref": [] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State", "label": "State and Local Jurisdiction [Member]" } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]" } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfNumberOfSharesOfCommonStockReservedForFutureIssuanceDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components", "label": "Equity Components [Axis]" } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "StatementScenarioAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario", "label": "Scenario [Axis]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]" } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r22", "r33", "r43", "r76" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)" } } }, "auth_ref": [] }, "acet_StockExchangedDuringPeriodSharesInConnectionWithMerger": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "StockExchangedDuringPeriodSharesInConnectionWithMerger", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange of common stock in connection with the Merger, shares", "label": "Stock Exchanged During Period Shares In Connection With Merger", "documentation": "Stock exchanged during period shares in connection with merger." } } }, "auth_ref": [] }, "acet_StockExchangedDuringPeriodValueInConnectionWithMerger": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "StockExchangedDuringPeriodValueInConnectionWithMerger", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Stock exchanged during period value in connection with merger.", "terseLabel": "Exchange of common stock in connection with the Merger", "label": "Stock Exchanged During Period Value In Connection With Merger" } } }, "auth_ref": [] }, "acet_StockIssuedDuringPeriodSharesConversionOfSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "StockIssuedDuringPeriodSharesConversionOfSecurities", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of shares of redeemable convertible preferred stock to shares of common stock in connection with the Merger, shares", "label": "Stock Issued During Period Shares Conversion Of Securities", "documentation": "Conversion of sharesaof redeemable convertible preferred stock to shares of common stock in connection with the Merger, shares" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Purchase of common stock under Employee Stock Purchase Plan, shares" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Issuance of common stock for cashless exercise of warrants, shares" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfEstimatedShareConsiderationOfCombinedCompanyParentheticalDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerParentheticalDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Number of common stock shares sold", "label": "Stock Issued During Period, Shares, New Issues", "verboseLabel": "Issuance of common stock related to financing, net of issuance costs of $823,940, shares" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesOther", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Issued During Period, Shares, Other", "label": "Stock Issued During Period, Shares, Other" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock upon vesting of restricted stock", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Shares Underlying Outstanding Options, Options exercised", "verboseLabel": "Issuance of common stock upon exercise of stock options, shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period" } } }, "auth_ref": [] }, "acet_StockIssuedDuringPeriodSharesUponAcceleratedVestingOfRSUWithMerger": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "StockIssuedDuringPeriodSharesUponAcceleratedVestingOfRSUWithMerger", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock upon accelerated vesting of restricted stock units in connection with the Merger (Shares)", "label": "Stock Issued During Period Shares Upon Accelerated Vesting Of R S U With Merger", "documentation": "Stock issued during period shares upon accelerated vesting of rsu with merger." } } }, "auth_ref": [] }, "acet_StockIssuedDuringPeriodSharesWarrantExercised": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "StockIssuedDuringPeriodSharesWarrantExercised", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise of warrant shares", "documentation": "Stock issued during period shares warrant exercised.", "label": "Stock Issued During Period Shares Warrant Exercised" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of shares of redeemable convertible preferred stock to shares of common stock in connection with the Merger", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Purchase of common stock under Employee Stock Purchase Plan" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Issuance of common stock for cashless exercise of warrants" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock related to financing, net of issuance costs of $823,940" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock upon exercise of stock options", "label": "Stock Issued During Period, Value, Stock Options Exercised" } } }, "auth_ref": [] }, "acet_StockIssuedDuringPeriodValueUponAcceleratedVestingOfRSUWithMerger": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "StockIssuedDuringPeriodValueUponAcceleratedVestingOfRSUWithMerger", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock upon accelerated vesting ofrestricted stock units in connection with the Merger", "label": "Stock Issued During Period Value Upon Accelerated Vesting Of R S U With Merger", "documentation": "Stock issued during period value upon accelerated vesting of rsu with merger." } } }, "auth_ref": [] }, "us-gaap_StockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockOptionMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Equity Option [Member]", "terseLabel": "Stock Option" } } }, "auth_ref": [] }, "acet_StockPriceDecrease": { "xbrltype": "percentItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "StockPriceDecrease", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Stock Price Decrease", "label": "Stock Price Decrease", "terseLabel": "Stock price declined" } } }, "auth_ref": [] }, "srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Stock Repurchase Program Number of Shares Authorized to be Repurchased", "terseLabel": "Common stock, shares repurchased under stock purchase agreement" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "label": "Equity, Attributable to Parent", "totalLabel": "Total stockholders' equity" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Parent [Abstract]", "terseLabel": "Stockholders' equity:" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity [Text Block]", "terseLabel": "Stockholders' Equity" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reverse stock split exchange ratio", "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Reverse Stock Split", "label": "Stockholders' Equity, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityReverseStockSplit": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityReverseStockSplit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reverse stock split", "label": "Stockholders' Equity, Reverse Stock Split" } } }, "auth_ref": [] }, "us-gaap_SubleaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubleaseIncome", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails": { "parentTag": "us-gaap_LeaseCost", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesSummaryOfLeaseCostsAndOtherInformationDetails" ], "lang": { "en-us": { "role": { "label": "Sublease Income", "negatedLabel": "Sublease Income", "terseLabel": "Sublease income" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Line Items]", "label": "Subsequent Event [Line Items]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Table]", "label": "Subsequent Event [Table]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type", "label": "Subsequent Event Type [Axis]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type", "label": "Subsequent Event Type [Domain]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventsPolicyPolicyTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Subsequent Events, Policy [Policy Text Block]", "terseLabel": "Subsequent Events Considerations" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEvents" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events", "label": "Subsequent Events [Text Block]" } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of Stock", "label": "Sale of Stock [Axis]" } } }, "auth_ref": [] }, "acet_SummaryOfSignificantAccountingPoliciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "SummaryOfSignificantAccountingPoliciesLineItems", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Summary Of Significant Accounting Policies [Line Items]", "terseLabel": "Summary Of Significant Accounting Policies [Line Items]", "documentation": "Summary of significant accounting policies." } } }, "auth_ref": [] }, "acet_SummaryOfSignificantAccountingPoliciesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "SummaryOfSignificantAccountingPoliciesTable", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Summary Of Significant Accounting Policies [Table]", "label": "Summary Of Significant Accounting Policies [Table]", "documentation": "Summary of significant accounting policies." } } }, "auth_ref": [] }, "acet_TRDFLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TRDFLiabilityMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfChangesInFairValueOfLevel3FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "TRDF Liability", "label": "T R D F Liability [Member]", "documentation": "TRDF Liability." } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r69" ] }, "us-gaap_TaxCreditCarryforwardAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TaxCreditCarryforwardAmount", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Tax Credit Carryforward, Amount", "terseLabel": "Tax credit carryforward, amount" } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TaxCreditCarryforwardAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit Carryforward", "label": "Tax Credit Carryforward [Axis]" } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TaxCreditCarryforwardNameDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit Carryforward, Name", "label": "Tax Credit Carryforward, Name [Domain]" } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TemporaryEquityCarryingAmountAttributableToParent", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying Value", "periodStartLabel": "Balance, temporary equity", "periodEndLabel": "Balance, temporary equity", "label": "Temporary Equity, Carrying Amount, Attributable to Parent" } } }, "auth_ref": [] }, "us-gaap_TemporaryEquitySharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TemporaryEquitySharesOutstanding", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares outstanding", "periodStartLabel": "Balance, temporary equity, shares", "periodEndLabel": "Balance, temporary equity, shares", "label": "Temporary Equity, Shares Outstanding" } } }, "auth_ref": [] }, "acet_TemporaryEquityStockConversionInConnectionWithMerger": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TemporaryEquityStockConversionInConnectionWithMerger", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of shares of redeemable convertible preferred stock to shares of common stock in connection with the Merger", "label": "Temporary Equity Stock Conversion In Connection With Merger", "documentation": "Temporary equity stock conversion in connection with merger." } } }, "auth_ref": [] }, "acet_TemporaryEquityStockConversionSharesInConnectionWithMerger": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TemporaryEquityStockConversionSharesInConnectionWithMerger", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "negatedLabel": "Conversion of shares of redeemable convertible preferred stock to shares of common stock in connection with the Merger, shares", "label": "Temporary Equity Stock Conversion Shares In Connection With Merger", "documentation": "Temporary Equity Stock Conversion Shares In Connection With Merger." } } }, "auth_ref": [] }, "us-gaap_TenantImprovements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TenantImprovements", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tenant improvements", "label": "Tenant Improvements" } } }, "auth_ref": [] }, "acet_TermLoanAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TermLoanAbstract", "lang": { "en-us": { "role": { "label": "Term Loan [Abstract]", "documentation": "Term loan abstract [Abstract]" } } }, "auth_ref": [] }, "acet_TermLoanAndNonFormulaAncillaryService": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TermLoanAndNonFormulaAncillaryService", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Term loan and non formula ancillary service", "documentation": "Term loan and non formula ancillary service", "terseLabel": "Term loan and non formula ancillary service" } } }, "auth_ref": [] }, "acet_TermLoanCashMaintain": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TermLoanCashMaintain", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Term Loan cash maintain", "label": "Term Loan cash maintain", "terseLabel": "Term Loan cash maintain" } } }, "auth_ref": [] }, "acet_TermLoanMaturityDate": { "xbrltype": "stringItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TermLoanMaturityDate", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term loan Maturity Date", "label": "Term loan Maturity Date", "documentation": "Term loan Maturity Date" } } }, "auth_ref": [] }, "acet_TermLoanToFinanceLeaseholdImprovements1": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TermLoanToFinanceLeaseholdImprovements1", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term loan to finance leasehold improvements", "documentation": "term loan to finance leasehold improvements 1", "label": "term loan to finance leasehold improvements 1" } } }, "auth_ref": [] }, "acet_TotalExternalProgramExpensesForProductCandidates": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TotalExternalProgramExpensesForProductCandidates", "crdr": "debit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfCompanysSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total external program expenses for product candidates", "label": "Total External Program Expenses For Product Candidates", "documentation": "Total External Program Expenses For Product Candidates", "totalLabel": "Total External Program Expenses For Product Candidates" } } }, "auth_ref": [] }, "acet_TotalLoanAccountsOutside": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TotalLoanAccountsOutside", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Total loan accounts outside", "label": "Total loan accounts outside", "terseLabel": "Total loan accounts outside" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r61" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r68" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r89" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r91" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments", "label": "Financial Instruments [Domain]" } } }, "auth_ref": [] }, "acet_TransitionAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TransitionAgreementMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transition Agreement [Member]", "label": "Transition Agreement [Member]", "documentation": "Transition agreement." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r92" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r93" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Expiration Date", "terseLabel": "Expiration Date" } } }, "auth_ref": [ "r93" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r91" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r91" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r94" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r92" ] }, "acet_TwoThousandEighteenEmployeeStockPurchasePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TwoThousandEighteenEmployeeStockPurchasePlanMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2018 Employee Stock Purchase Plan", "label": "Two Thousand Eighteen Employee Stock Purchase Plan [Member]", "documentation": "Two thousand eighteen employee stock purchase plan." } } }, "auth_ref": [] }, "acet_TwoThousandEighteenStockIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TwoThousandEighteenStockIncentivePlanMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2018 Stock Incentive Plan", "label": "Two Thousand Eighteen Stock Incentive Plan [Member]", "documentation": "Two thousand eighteen stock incentive plan." } } }, "auth_ref": [] }, "acet_TwoThousandFifteenStockIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TwoThousandFifteenStockIncentivePlanMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2015 Stock Incentive Plan Member", "label": "Two Thousand Fifteen Stock Incentive Plan [Member]", "documentation": "Two Thousand Fifteen Stock Incentive Plan Member." } } }, "auth_ref": [] }, "acet_TwoThousandFourteenAndTwoThousandFifteenStockIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TwoThousandFourteenAndTwoThousandFifteenStockIncentivePlanMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2014 and 2015 Stock Incentive Plan", "label": "Two Thousand Fourteen And Two Thousand Fifteen Stock Incentive Plan [Member]", "documentation": "Two thousand fourteen and two thousand fifteen stock incentive plan." } } }, "auth_ref": [] }, "acet_TwoThousandFourteenStockIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TwoThousandFourteenStockIncentivePlanMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2014 Stock Incentive Plan Member", "label": "Two Thousand Fourteen Stock Incentive Plan [Member]", "documentation": "Two Thousand Fourteen Stock Incentive Plan Member." } } }, "auth_ref": [] }, "acet_TwoThousandSeventeenAndTwoThousandEighteenStockIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TwoThousandSeventeenAndTwoThousandEighteenStockIncentivePlanMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2017 and 2018 Stock Incentive Plan", "label": "Two Thousand Seventeen And Two Thousand Eighteen Stock Incentive Plan [Member]", "documentation": "Two thousand seventeen and two thousand eighteen stock incentive plan." } } }, "auth_ref": [] }, "acet_TwoThousandTwentyFivePre-FundedWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TwoThousandTwentyFivePre-FundedWarrantMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand Twenty Five Pre-Funded Warrant [Member]", "documentation": "Two Thousand Twenty Five Pre-Funded Warrant [Member]", "terseLabel": "2025 Pre-Funded Warrant [Member]" } } }, "auth_ref": [] }, "acet_TwoThousandTwentyLoanAmendmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TwoThousandTwentyLoanAmendmentMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Two Thousand Twenty Loan Amendment [Member]", "label": "Two Thousand Twenty Loan Amendment [Member]", "terseLabel": "2020 Loan Amendment [Member]" } } }, "auth_ref": [] }, "acet_TwoThousandTwentyOneLoanAmendmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TwoThousandTwentyOneLoanAmendmentMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2021 Loan Amendment [Member]", "label": "Two Thousand Twenty One Loan Amendment Member", "documentation": "Two Thousand Twenty One Loan Amendment Member" } } }, "auth_ref": [] }, "acet_TwoThousandTwentyTwoLoanAmendmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "TwoThousandTwentyTwoLoanAmendmentMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2022 Loan Amendment [Member]", "label": "Two Thousand Twenty Two Loan Amendment [Member]", "documentation": "Two Thousand Twenty Two Loan Amendment [Member]" } } }, "auth_ref": [] }, "us-gaap_TypeOfAdoptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TypeOfAdoptionMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Standards Update", "label": "Accounting Standards Update [Domain]" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TypeOfArrangementAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "auth_ref": [] }, "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "USGovernmentAgenciesDebtSecuritiesMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "US Government Agency Bonds", "label": "US Government Agencies Debt Securities [Member]" } } }, "auth_ref": [] }, "us-gaap_USTreasurySecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "USTreasurySecuritiesMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableDebtSecuritiesDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "US Treasury Securities [Member]", "terseLabel": "Treasury Securities" } } }, "auth_ref": [] }, "acet_UnderwritingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "UnderwritingAgreementMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Underwriting Agreement [Member]", "documentation": "Underwriting Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_UnderwritingCommitments": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UnderwritingCommitments", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Underwriting Commitments", "terseLabel": "Underwriting Agreement to purchase" } } }, "auth_ref": [] }, "acet_UnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "UnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Underwriting discounts and commissions and other offering expenses", "label": "Underwriting Discounts And Commissions And Other Offering Expenses", "documentation": "Underwriting discounts and commissions and other offering expenses." } } }, "auth_ref": [] }, "acet_UnderwrittenPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "UnderwrittenPublicOffering", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Public Offering Underwritten", "documentation": "Underwritten Public Offering", "label": "Underwritten Public Offering" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r88" ] }, "acet_UnrealizedGainOnTreasurySecuritiesNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "UnrealizedGainOnTreasurySecuritiesNetOfTax", "crdr": "credit", "calculation": { "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Unrealized Gain on Treasury Securities Net of Tax", "documentation": "Unrealized Gain on Treasury Securities Net of Tax", "terseLabel": "Unrealized gain on treasury securities, net of tax" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetail" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at the beginning of the year", "terseLabel": "Unrecognized tax benefits", "periodEndLabel": "Balance at the end of the year", "label": "Unrecognized Tax Benefits" } } }, "auth_ref": [] }, "acet_UnrecognizedTaxBenefitsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "UnrecognizedTaxBenefitsAmount", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits, Amount", "label": "Unrecognized Tax Benefits Amount", "documentation": "Unrecognized Tax Benefits Amount" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetail" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions", "terseLabel": "Adjustment based on tax positions related to current year" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "crdr": "debit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetail" ], "lang": { "en-us": { "role": { "negatedLabel": "Adjustment based on tax positions related to prior years", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "terseLabel": "Adjustment based on tax positions related to prior years" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment based on tax positions related to prior years", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions" } } }, "auth_ref": [] }, "acet_UnrecognizedTaxBenefitsPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "UnrecognizedTaxBenefitsPercent", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionForBenefitFromIncomeTaxesDiffersFromFederalStatutoryRateToLossBeforeTaxesDetail" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits Percent", "documentation": "Unrecognized Tax Benefits Percent", "terseLabel": "Unrecognized tax benefits ,Percent" } } }, "auth_ref": [] }, "acet_UnsoldCommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "UnsoldCommonStockValue", "crdr": "credit", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureAtTheMarketATMOfferingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unsold Common Stock Value", "label": "Unsold Common Stock Value", "documentation": "Unsold Common Stock Value" } } }, "auth_ref": [] }, "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UnusualRiskOrUncertaintyByNatureAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unusual Risk or Uncertainty, Nature", "label": "Unusual Risk or Uncertainty, Nature [Axis]" } } }, "auth_ref": [] }, "us-gaap_UnusualRiskOrUncertaintyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UnusualRiskOrUncertaintyNatureDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureLicenseFundingAndOtherAgreementsAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Unusual Risk or Uncertainty, Nature [Domain]", "terseLabel": "Unusual Risk or Uncertainty, Nature" } } }, "auth_ref": [] }, "acet_UnvestedCommonStockFromEarlyExerciseOfOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "UnvestedCommonStockFromEarlyExerciseOfOptionsMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unvested Early Exercised Common Stock Options", "label": "Unvested Common Stock From Early Exercise Of Options [Member]", "documentation": "Unvested common stock from early exercise of options." } } }, "auth_ref": [] }, "acet_UnvestedRestrictedStockUnitsOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "UnvestedRestrictedStockUnitsOutstanding", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureBusinessCombinationScheduleOfSummarizesPurchasePriceInMergerParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unvested restricted stock units outstanding", "label": "Unvested Restricted Stock Units Outstanding", "documentation": "Unvested restricted stock units outstanding." } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UseOfEstimates", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VariableInterestEntityDisclosureTextBlock", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureShanghaiAdicetBiotechnologyCoLtdTheAdicetVie" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity Disclosure [Text Block]", "terseLabel": "Shanghai Adicet Biotechnology Co., Ltd. (the Adicet VIE)" } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityVIEActivitiesOfVIE": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VariableInterestEntityVIEActivitiesOfVIE", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusinessAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity transfer agreement", "label": "Variable Interest Entity, Qualitative or Quantitative Information, Activities of VIE" } } }, "auth_ref": [] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VariableRateAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate", "label": "Variable Rate [Axis]" } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VariableRateDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate", "label": "Variable Rate [Domain]" } } }, "auth_ref": [] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VestingAxis", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting", "label": "Vesting [Axis]" } } }, "auth_ref": [] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VestingDomain", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting", "label": "Vesting [Domain]" } } }, "auth_ref": [] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]", "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year" } } }, "auth_ref": [ "r57" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WarrantMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "terseLabel": "Warrant" } } }, "auth_ref": [] }, "acet_WarrantsOutstandingAndExercisableWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "WarrantsOutstandingAndExercisableWeightedAverageRemainingContractualTerm", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsDetails", "http://www.adicetbio.com/20251231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants outstanding and exercisable, Weighted average remaining contractual term", "label": "Warrants Outstanding And Exercisable Weighted Average Remaining Contractual Term", "documentation": "Warrants Outstanding And Exercisable Weighted Average Remaining Contractual Term" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageLimitedPartnershipUnitsOutstandingDiluted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageLimitedPartnershipUnitsOutstandingDiluted", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average shares used in computing net loss per share, diluted", "label": "Weighted Average Limited Partnership Units Outstanding, Diluted" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total", "terseLabel": "Weighted-average common shares used in computing net loss per share, diluted" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfSharesIssuedBasic", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average shares used in computing net loss per share, basic", "label": "Weighted Average Number of Shares Issued, Basic" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total", "terseLabel": "Weighted-average common shares used in computing net loss per share, basic" } } }, "auth_ref": [] }, "acet_WestportOfficeParkLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.adicetbio.com/20251231", "localname": "WestportOfficeParkLlcMember", "presentation": [ "http://www.adicetbio.com/20251231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Westport Office Park, LLC", "label": "Westport Office Park, LLC [Member]", "documentation": "Westport Office Park, LLC member" } } }, "auth_ref": [] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]", "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested" } } }, "auth_ref": [ "r55" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "2" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "1" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2", "Subparagraph": "i" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2", "Subparagraph": "ii" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2", "Subparagraph": "iii" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r20": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r21": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r22": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r23": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r24": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r25": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r26": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r27": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r28": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r29": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r30": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r31": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r32": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r33": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r34": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r35": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r36": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r37": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r38": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r39": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r40": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r41": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r42": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r43": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r44": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r45": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r46": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r47": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r48": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r49": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r50": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r51": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r52": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r53": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r54": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r55": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r56": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r57": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r58": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r59": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r60": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r61": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r62": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r63": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r64": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r65": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r66": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r67": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r68": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r69": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r70": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r71": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r72": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r73": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r74": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r75": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r76": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r77": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r78": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r79": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r80": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r81": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r82": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r83": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r84": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r85": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r86": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r87": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r88": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r89": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r90": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r91": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r92": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r93": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r94": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r95": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r96": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106" }, "r97": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1" }, "r98": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r99": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r100": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r101": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "2" }, "r102": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "1" }, "r103": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2" }, "r104": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2", "Subparagraph": "i" }, "r105": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2", "Subparagraph": "ii" }, "r106": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2", "Subparagraph": "iii" }, "r107": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r108": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r109": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r110": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r111": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r112": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-X", "Number": "210", "Section": "2", "Subsection": "2" }, "r113": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r114": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } }